etoposide has been researched along with Local Neoplasm Recurrence in 936 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 76 (8.12) | 18.7374 |
| 1990's | 231 (24.68) | 18.2507 |
| 2000's | 284 (30.34) | 29.6817 |
| 2010's | 244 (26.07) | 24.3611 |
| 2020's | 101 (10.79) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, CH; Liu, FY; Tung, HJ; Wang, CC | 1 |
| de Lima, VCC; Filho, JS; Germano, JN; Matias Vieira, GM; Moura, FL; Sapelli, J | 1 |
| Bansal, D; Jain, R; Kakkar, N; Menon, P; Radhika, S; Rao, KLN; Trehan, A | 1 |
| Bagaria, S; Gabriel, E; Kaplan, JL; Mangum, CA; Shoukry, M | 1 |
| Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
| Atalla, A; Costa, LJM; Duarte, FB; Leal, CTS; Neto, AEH; Pereira, J; Sabioni, BS; Tavares, RB | 1 |
| Albers, P; Bolenz, C; Brandt, MP; Dieckmann, KP; Dotzauer, R; Haferkamp, A; Heidenreich, A; Hiester, A; Loosen, SH; Nestler, T; Nettersheim, D; Paffenholz, P; Pfister, D; Ruckes, C; Ruf, C; Schmelz, HU; Syring, I; Zengerling, F | 1 |
| Ashkenazi, M; Avni, B; Grisariu, S; Lebel, E; Stepensky, P; Vainstein, V; Zimran, E | 1 |
| Acar, R; Aykan, MB; Erturk, I; Karadurmus, N; Yildiran, GS; Yildiz, B | 1 |
| Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
| Adachi, S; Hiramatsu, H; Kato, I; Mizowaki, T; Nakamoto, Y; Okamoto, T; Saida, S; Sakamoto, A; Shimizu, H; Takita, J; Taura, K; Umeda, K; Uto, M | 1 |
| Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
| Hamada, M; Ichikawa, D; Imaya, M; Kawashima, N; Kojima, S; Miwata, S; Muramatsu, H; Narita, A; Narita, K; Nishikawa, E; Nishio, N; Takahashi, Y; Wakamatsu, M; Yamamori, A; Yoshida, T | 1 |
| Assane, C; Malo, FC; Mansouri, S | 1 |
| Gentille, C; Joshi, J; Pingali, SR; Randhawa, J; Sarfraz, H; Shah, S | 1 |
| Borawska, A; Chełstowska, M; Dąbrowska-Iwanicka, A; Domańska-Czyż, K; Druzd-Sitek, A; Giebel, S; Knopińska-Posłuszny, W; Konecki, R; Kumiega, B; Lange, A; Malenda, A; Michalski, W; Mordak-Domagała, M; Najda, J; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Pluta, A; Popławska, L; Romejko-Jarosińska, J; Rymkiewicz, G; Świerkowska, M; Szpila, T; Szymański, M; Targoński, Ł; Taszner, M; Walewski, J; Zaucha, JM | 1 |
| Abraham, J; Agbetiafa, K; Ahle, G; Bonmati, C; Bouabdallah, K; Bouabdallah, R; Bourget, P; Casasnovas, O; Charron, C; Chauchet, A; Chinot, O; Choquet, S; Cornillon, J; Damaj, G; Delwail, V; Dorvaux, V; Fabbro, M; Fornecker, LM; Ghesquières, H; Giordan, Q; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Houot, R; Jabeur, W; Jardin, F; Le Garff-Tavernier, M; Malaise, D; Marolleau, JP; Moluçon-Chabrot, C; Morschhauser, F; Nichelli, L; Oberic, L; Peyrade, F; Plessier, A; Roland, V; Schenone, L; Schmitt, A; Soussain, C; Taillandier, L; Tanguy, ML; Tempescul, A; Thieblemont, C; Touitou, V; Ursu, R; Wantz-Mézières, S; Waultier-Rascalou, A; Willems, L | 1 |
| Feng, F; Ji, M; Jiang, S; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J | 1 |
| Castillo, JJ; Dittus, C; Miller, JA; Wehbie, R | 1 |
| Bashey, A; Brown, S; Holland, HK; Jackson, KC; Morris, LE; Shegda, N; Solh, M; Solomon, SR; Zhang, X | 1 |
| Byers, L; Califano, R; Chafin, W; Cho, BC; Faivre-Finn, C; Jabbour, SK; Kato, T; Lai, WV; Rimner, A; Rudin, CM; Yu, J; Yu, L; Zhao, B | 1 |
| Johnson, PWM | 1 |
| Imai, H; Kagamu, H; Kaira, K; Kanazawa, K; Kishikawa, T; Minato, K; Minemura, H; Mouri, A; Nagai, Y; Shiihara, J; Shiono, A; Taniguchi, H; Tsuda, T; Wasamoto, S; Yamada, Y; Yamaguchi, O | 1 |
| Castellino, SM; Cho, S; Constine, LS; Hodgson, D; Hoppe, BS; Keller, FG; Kelly, KM; Kessel, S; McCarten, KM; Parekh, A; Pei, Q; Schwartz, CL; Wu, Y | 1 |
| Chen, Q; Huang, J; Lin, L; Lv, D; Pan, W; Wu, G; Wu, X; Yan, S | 1 |
| Abdulhaq, H; Baweja, A; Brem, EA; Daniel, CE; Gaut, D; Lee, M; Ly, J; Oliai, C; Othman, T; Penaloza, J; Pinter-Brown, L; Reid, J; Tuscano, J; Zhang, S | 1 |
| Abate, A; Berruti, A; Cosentini, D; Cremaschi, V; Grisanti, S; Laganà, M; Rossini, E; Sigala, S; Tamburello, M; Turla, A | 1 |
| Guo, F; Pi, G; Shi, H; Wang, H; Xia, H; Xu, P | 1 |
| Baudin, E; Beaulaton, C; Blanchet, O; Chatelain, D; Do Cao, C; Ducreux, M; Faron, M; Hadoux, J; Hautefeuille, V; Hervieu, V; Hescot, S; Joubert Zakeyh, J; Kanaan, C; Laboureau, S; Leteurtre, E; Lombard-Bohas, C; Marchal, A; Perrier, M; Petorin, C; Rousselet, MC; Scoazec, JY; Tauveron, I; Walter, T | 1 |
| André, M; Berriolo-Riedinger, A; Borel, C; Brice, P; Edeline, V; Feugier, P; Gac, AC; Gastinne, T; Ghesquières, H; Guidez, S; Le Bras, F; Morschhauser, F; Nicolas-Virelizier, E; Quittet, P; Ribrag, V; Stamatoullas, A; Vander Borght, T | 1 |
| Imai, H; Kaburagi, T; Kagamu, H; Kaira, K; Kanazawa, K; Kishikawa, T; Masubuchi, K; Minato, K; Minemura, H; Nagai, Y; Shiihara, J; Shiono, A; Takechi, H; Taniguchi, H; Tsuda, T; Umeda, Y; Wasamoto, S; Yamada, Y | 1 |
| Fukuhara, M; Matsumura, Y; Mine, H; Muto, S; Okabe, N; Ozaki, Y; Shio, Y; Suzuki, H; Takagi, H; Watanabe, M; Yamaguchi, H | 1 |
| Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
| Adachi, H; Atsuta, Y; Doki, N; Hashimoto, S; Igarashi, A; Kaito, S; Kishida, Y; Kito, S; Kobayashi, T; Konishi, T; Konuma, R; Marumo, A; Mukae, J; Murofushi, KN; Nagata, A; Najima, Y; Noguchi, Y; Ogawa, H; Ohashi, K; Shimizu, H; Shingai, N; Toya, T; Wada, A; Yamada, Y | 1 |
| Bang, SM; Byun, JM; Kim, JS; Kim, K; Koh, Y; Lee, JJ; Min, CK; Yoon, SS | 1 |
| Castellino, SM; Charpentier, AM; Cho, S; Dave, H; Henderson, TO; Hodgson, D; Hoppe, BS; Horton, T; Keller, FG; Kelly, KM; McCarten, K; Parsons, SK; Pei, Q; Punnett, A; Wu, Y | 1 |
| Hou, SL; Li, L; Lian, K; Zhang, QH | 1 |
| Cheng, Q; Hou, M; Li, L; Li, T; Yu, J; Zha, S; Zheng, Q | 1 |
| Blanco-Alcaina, E; Carrillo-García, J; Durán, J; Hindi, N; Jiménez, N; Luna, P; Martín-Broto, J; Moura, DS; Ramos, R; Renshaw, M; Sancho, P | 1 |
| Badira, CP; Banavali, S; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Muckaden, MA; Prasad, M; Qureshi, S; Ramadwar, M; Ramanathan, S; Vora, T | 1 |
| Arndt, C; Boron, M; Buxton, A; Chen, HX; Crompton, BD; Daldrup-Link, H; DuBois, SG; Eutsler, E; Glade-Bender, J; Gorlick, RG; Hayes, A; Hill-Kayser, C; Janeway, KA; Kolb, EA; Krailo, MD; Laack, N; Lessnick, SL; Rakheja, D; Randall, RL; Reed, DR; Reid, JM; Seibel, NL; Teot, L; Terezakis, S; Womer, R | 1 |
| Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S | 1 |
| Alva, E; Bukowinski, A; Cramer, SL; Daley, J; Escoto, H; Fair, D; Hartt, D; Kim, H; LeBlanc, Z; Merjaneh, N; Metts, J; Pressey, JG; Ray, A; Szabo, S; Todd, K; Watanbe, M | 1 |
| Kim, KD; Lee, KY; Shin, WY | 1 |
| Faria, TMV; Guimarães, RFDC; Jorge, GEM; Lopes, LF; Macedo, CRPD; Navarro, G; Seber, A; Vidal, DO; Villela, NC; Zecchin, VG | 1 |
| Alamgeer, M; Cain, JE; Chen, J; DeVeer, M; Ganju, V; Garama, DJ; Gough, DJ; Guanizo, AC; Inampudi, C; Jakasekara, WSN; Luong, Q; Thakur, N; Watkins, DN | 1 |
| Bai, B; Gao, Y; He, Y; Huang, C; Huang, H; Ping, L; Shi, L; Wang, X | 1 |
| Al-Ezzi, EM; Crump, M; Hamilton, RJ; Hansen, AR; Hotte, SJ; Jiang, DM; Kollmannsberger, CK; Kuruvilla, J; Nappi, L; North, SA; Soulières, D; Winquist, E; Wood, L; Zahralliyali, A | 1 |
| Burke, SM; Ghasemi, M; Goey, AKL; Hernandez-Ilizaliturri, FJ; Lin, LH; Mager, DE; Mavis, CK; Nichols, JR; Torka, P | 1 |
| Akagi, K; Dotsu, Y; Fukuda, M; Gyotoku, H; Hayashi, F; Hisamatsu, Y; Ikeda, T; Kinoshita, A; Morinaga, R; Mukae, H; Nagashima, S; Nakatomi, K; Ogata, R; Ono, S; Senju, H; Shimada, M; Soda, H; Sugasaki, N; Tagawa, R; Takemoto, S; Taniguchi, H; Tomono, H; Umeyama, Y | 1 |
| Alía Navarro, V; Barrill Corpa, AM; De Frutos González, B; Ferreiro Monteagudo, R; Ferrer Gómez, A; Martínez Delfrade, Í; Morón García, B; Peñas García, B; Perna Monroy, C; Sotoca Rubio, P | 1 |
| Jiang, X; Tang, X; Wang, X; Yao, H; Zeng, Y | 1 |
| Chargari, C; Coppin, R; Faure-Conter, C; Fresneau, B; Guérin, F; Martelli, H; Orbach, D; Pasquet, M; Patte, C; Piguet, C; Saumet, L; Sudour-Bonnange, H; Vérité, C | 1 |
| Abdelal, S; Abu-Hijlih, R; Abuhijla, F; Almousa, A; Halalsheh, H; Ismail, T; Jaber, O; Salah, S; Shehadeh, A; Sultan, I; Yaser, S | 1 |
| Buckner, J; Duma, N; Halfdanarson, T; Reed, CT | 1 |
| Albert, DM; Ali, MJ; Chévez-Barrios, P; Chintagumpala, M; Eagle, RC; Gao, Y; Honavar, SG; Khetan, V; Krailo, M; Leahey, AM; Matthay, K; Meadows, A; O'Brien, J; Piao, J; Vemuganti, G | 1 |
| Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV | 1 |
| Dandulakis, M; Mayer, R; Richards, S; Roque, DM; Staats, PN | 1 |
| Hagiwara, S; Nagai, H; Okada, S; Saito, AM; Uehira, T | 1 |
| Biasoni, D; Bisogno, G; Boldrini, R; Conte, M; Crocoli, A; D'Angelo, P; Dall'Igna, P; De Pasquale, MD; Inserra, A; Miele, E; Siracusa, F; Spreafico, F; Terenziani, M | 1 |
| Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J | 1 |
| De Petris, L; Fang, F; Lewensohn, R; Pettersson, A; Tendler, S; Viktorsson, K; Zhan, Y | 1 |
| Cafferty, FH; Hennig, I; Huddart, RA; Shamash, J; Stenning, SP; White, JD | 1 |
| Bhatla, N; Khurana, S; Kumar, L; Kumar, S; Malik, PS; Ray, MD; Sharma, A | 1 |
| An, HY; Choi, HJ; Choi, JY; Hong, KT; Kang, HJ; Kim, BK; Shin, HY | 1 |
| Ahmadi, H; Daneshmand, S; Hamilton, R; Kollmannsberger, C; Nappi, L; Nichols, C | 1 |
| Di Sabatino, A; Furlan, D; La Rosa, S; Martino, M; Neri, G; Perfetti, V; Sessa, F; Solcia, E; Vanoli, A; Viglio, A | 1 |
| Bagot, M; Battistella, M; Bouaziz, JD; Brice, P; Dangien, A; de Masson, A; Lebbé, C; Moins-Teisserenc, H; Mourah, S; Peffault de Latour, R; Ram-Wolff, C; Roelens, M | 1 |
| Aparicio, J; Arranz, JA; Bastús, R; Castellano, D; Durán, I; García Del Muro, X; García-Sánchez, J; Germà, JR; Gironés, R; Gumà, J; Maroto, P; Meana, JA; Ochenduszko, S; Sagastibeltza, N; Terrasa, J | 1 |
| Adachi, S; Akazawa, R; Arakawa, Y; Hiramatsu, H; Kato, I; Moritake, H; Okamoto, T; Saida, S; Sakamoto, A; Sumiyoshi, S; Takita, J; Umeda, K | 1 |
| Advani, RH; Corbelli, KS; Daadi, SE; Hoppe, RT; Qian, Y; Rosenberg, SA; Von Eyben, R; Weil, CR | 1 |
| Hattori, Y; Hayata, N; Kawai, K; Mitsumori, K; Nakamura, K; Ohnishi, H; Takahashi, T | 1 |
| Kajita, N; Makimoto, A; Miyahara, S; Saito, Y; Yuza, Y | 1 |
| Aoki, S; Hara, K; Muramatsu, H; Nakamura, K; Nishikawa, G; Ono, K; Takayanagi, Y; Tobiume, M; Yamada, Y | 1 |
| Endo, M; Fukuda, K; Hasegawa, N; Hattori, J; Hirose, S; Hyodo, I; Ishige, K; Kawai, H; Komatsu, Y; Mizokami, Y; Mizui, T; Nagase, M; Sato, M; Yamamoto, Y; Yamaura, M | 1 |
| Bas, Z; Dalvin, LA; Pacheco, R; Rao, R; Shields, CL; Tadepalli, S; Vaidya, S | 1 |
| Alexandre, J; Bello-Roufai, D; Berton, D; Blanc-Durand, F; Chaltiel, D; Collard, O; Dupre, PF; Fabbro, M; Faller, É; Floquet, A; Genestie, C; Guillemet, C; Hardy-Bressard, AC; Kalbacher, E; Lefeuvre-Plesse, C; Meriaux, É; Pautier, P; Provansal, M; Ray-Coquard, I | 1 |
| Asanuma, K; Fujishima, F; Furukawa, T; Hata, T; Hatta, W; Koike, T; Masamune, A; Saito, M; Unno, M | 1 |
| Cheah, CY; Cochrane, T; Harwood, M; Hodges, G; Ku, M; Lagerlof, I; Lim, K; Tam, C; Tan, X | 1 |
| Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
| Arrieta, O; Lara-Mejía, L; Zatarain-Barrón, ZL | 1 |
| Noda, T; Oyama, T; Shimada, A; Washio, K | 1 |
| Adachi, S; Goto, H; Hasegawa, D; Iwamoto, S; Kakuda, H; Koh, K; Miyamura, T; Moritake, H; Nakayama, H; Saito, A; Shiba, N; Shimada, A; Taga, T; Tanaka, S; Terui, K; Tomizawa, D; Yuza, Y | 1 |
| Asano, N; Igarashi, T; Izutsu, K; Katayama, N; Kato, K; Kinoshita, T; Miyawaki, K; Miyazaki, K; Nishikawa, M; Nishikori, M; Nishimura, Y; Ohata, K; Ohshima, K; Okamoto, M; Sakai, R; Sunami, K; Suzumiya, J; Takahashi, N; Tamaru, S; Yamada, T; Yamaguchi, M; Yamamoto, G; Yano, H; Yoshida, I | 1 |
| Anticoli Borza, P; Banchi, M; Battistini, R; Bocci, G; Cox, MC; Di Gregorio, F; Di Napoli, A; Marcheselli, L; Orlandi, P; Patti, C; Pelliccia, S | 1 |
| Alpdogan, SO; Carabasi, M; Chapman, A; DiMeglio, M; Filicko-OHara, J; Flomenberg, N; Gaballa, S; Ghimire, S; Gong, J; Martinez-Outschoorn, U; Pan, J; Porcu, P; Pro, B; Ramirez, M; Rose, L; Wagner, JL; Weiss, M | 1 |
| Chan, JY; Farid, M; Lim, C; Lim, ST; Martin, P; Poon, E; Somasundaram, N; Tang, T; Tao, M; Toh, SQ; Yan, SX; Yunon, MJ | 1 |
| Chen, H; Horita, N; Takeshi, K | 1 |
| Baize, N; Chouaid, C; Monnet, I | 1 |
| Chen, BA; Gao, C; Gu, Y; Wu, X; Zhang, J | 1 |
| Ai, WZ; Andreadis, CB; Damon, L; Fakhri, B; Huang, CY; Hunter, B; Kambhampati, S; Kaplan, L; Martin, T; Pampaloni, M; Varnavski, A | 1 |
| Cho, H; Koo, HH; Lee, JW; Lim, DH; Ma, Y; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Horan, M; Maddox, JM; Osborne, W; Shrubsole, C; Tafesh, L | 1 |
| Chen, J; Liu, L; Luo, X; Tang, X; Wang, L; Wang, X; Xiao, Q; Xiong, Y; Zhang, H | 1 |
| Bas, Z; Dalvin, LA; Leahey, AM; Rao, R; Shah, A; Shields, CL; Tadepalli, S | 1 |
| Chen, XJ; Chen, YM; Guo, Y; Liu, F; Liu, LP; Liu, TF; Liu, XM; Quan Qi, B; Ruan, M; Yang, WY; Zhang, AL; Zhang, L; Zhu, XF; Zou, Y | 1 |
| Bay, JO; Chatelut, E; Chevreau, C; Ciccolini, J; Culine, S; Delva, R; Filleron, T; Fizazi, K; Flechon, A; Gallois, Y; Gravis, G; Gross-Goupil, M; Guitton, J; Lelièvre, B; Lotz, JP; Massard, C; Moeung, S; Mourey, L; Olivier, P; Paci, A; Thomas, F | 1 |
| Blackmon, S; Bland, RE; Butler, EB; Chevli, N; Farach, AM; Mathews, T; Okoye, EI; Pino, R; Teh, BS | 1 |
| Chauhan, R; Khurana, S; Kumar, L; Kumar, S; Malik, PS; Mathur, S; Sharma, A; Singh, M; Sreenivas, V | 1 |
| Birkmann, J; Blaudszun, AR; Bornhäuser, M; Ehninger, G; Fiedler, F; Fricke, S; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Kürzel, S; Schaefer-Eckart, K; Stahl, L | 1 |
| Bode, P; Manzella, G; Moonamale, DC; Römmele, M; Schäfer, BW; Wachtel, M | 1 |
| Albers, P; Dieckmann, KP; Fimmers, R; Fingerhut, A; Hartmann, M; Heidenreich, A; Hiester, A; Kliesch, S; Köhrmann, KU; Krege, S; Kwasny, P; Lehmann, J; Loy, V; Niegisch, G; Pechoel, M; Schmelz, HU; Siener, R; Wittekind, C | 1 |
| Alrjoub, MM; Alshriedeh, O; Amarin, Z; Sindiani, A | 1 |
| Borchmann, P; Breywisch, F; Damaschin, C; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Mathas, S; Meissner, J; Plütschow, A; Sökler, M; Topp, MS; von Tresckow, B; Vucinic, V; Zimmermann, A | 1 |
| Absalon, MJ; Ahmed, A; August, K; Baker, SD; Boklan, J; Brown, PA; Cooper, TM; Gore, L; Li, L; Macy, ME; Magoon, D; Narendran, A; Pollard, J; Sison, EAR; Trippett, T | 1 |
| Boulos, S; Mazhar, D; Warren, AY; Wong, HH | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Borriello, L; Cherryholmes, G; DeClerck, YA; Lee, H; Li, W; Lifshitz, V; Makovski-Silverstein, A; Priceman, SJ; Yu, H | 1 |
| Ayed, AO; Chu, B; Farooq, U; Galanina, N; Link, BK; Malecek, MK; Maurer, M; Nabhan, C; Nowakowski, GS; Petrich, AM; Rozell, S; Trifilio, S | 1 |
| Claret, L; Copeland, AR; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Hagemeister, FB; Hu, B; Nastoupil, LJ; Neelapu, S; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, J; Samaniego, F; Turturro, F; Westin, JR; Younes, A | 1 |
| Ahmed, SK; DuBois, SG; Geller, DS; Gorlick, RG; Granowetter, L; Grier, HE; Harmsen, WS; Janeway, KA; Krailo, M; Laack, NNI; Marcus, KJ; Randall, RL; Sorger, JI; Womer, RB | 1 |
| Alapetite, C; Calaminus, G; Frappaz, D; Garre, ML; Göbel, U; Kortmann, RD; Krefeld, B; Mann, JR; Murray, MJ; Nicholson, JC; Pietsch, T; Ricardi, U; Saran, F; Vasiljevic, A | 1 |
| Li, Q; Sun, L; Wen, F; Zhang, P; Zheng, H; Zhou, J; Zhou, K | 1 |
| Belogurova, M; Berthold, F; Ernst, A; Hömberg, M; Mazanek, P; Proleskovskaya, I; Sterba, J | 1 |
| Alenxandrova, K; Arfi-Rouche, J; Bourhis, JH; Castilla-Llorente, C; Danu, A; Ghez, D; Khalife-Saleh, N; Koscielny, S; Lapierre, V; Lazarovici, J; Legoupil, C; Michot, JM; Pilorge, S; Ribrag, V; Saleh, K | 1 |
| Belada, D; Bermudez Silva, CD; Bouabdallah, K; Cavalli, F; Costa, LJ; Fan, J; Fayad, L; Hino, M; Ikeda, T; Kattan, JG; Kim, WS; Kuruvilla, J; Larouche, JF; Louveau, AL; Mayer, J; Ogura, M; Ozcan, M; Rigacci, L; Shi, Y; Tobinai, K; Vanazzi, A; Voi, M; Witzig, TE; Wu, C; Zhu, J | 1 |
| Fukui, T; Igawa, S; Katagiri, M; Kubota, M; Kurahayashi, S; Mitsufuji, H; Naoki, K; Nishinarita, N; Okuma, Y; Ono, T; Ozawa, T; Sasaki, J; Shirasawa, M; Sone, H; Sugimoto, A; Sugita, K | 1 |
| Abdel-Rahman, S; Angele, M; Belka, C; Daugaard, S; Dürr, HR; Ghadjar, P; Gronchi, A; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Knösel, T; Lindner, LH; Mansmann, U; Mella, O; Reichardt, P; Salat, C; Schmidt, M; Verweij, J; Vujaskovic, Z; Wessalowski, R; Wust, P | 1 |
| Anwer, F; Guillén-Rodríguez, JM; Heard, K; Inclán, L; Mahadevan, D; Persky, DO; Puvvada, SD; Rivera, XI; Schatz, JH; Yan, J | 1 |
| Pinkhas, D; Toocheck, C | 1 |
| Andraos, TY; Aristophanous, M; Chuang, HH; Dabaja, BS; Fanale, MA; Gunther, JR; Hancock, D; Ludmir, EB; Mikhaeel, NG; Milgrom, SA; Nastoupil, L; Oki, Y; Pham, M; Pinnix, CC; Wirth, A | 1 |
| Bergin, K; Coutsouvelis, J; Fedele, P; Grigoriadis, G; Kalff, A; Low, MSY; Spencer, A; Walker, P; Yuen, HLA | 1 |
| Choi, KH; Hur, SY; Kim, JY; Kim, YS; Lee, DS; Lee, SW; Lee, YH; Park, HH; Park, JS; Sung, S; Yoon, SC | 1 |
| Das, A; Shuayb, M; Uddin, MN | 1 |
| Albany, C | 1 |
| Dührsen, U; Lamm, W; Liebregts, T; Turki, AT | 1 |
| Amemiya, K; Hirotsu, Y; Iijima, Y; Kakizaki, Y; Kobayashi, Y; Miyashita, Y; Mochizuki, H; Omata, M; Oyama, T; Tsutsui, T; Uchida, Y | 1 |
| Akizawa, Y; Kanno, T; Matsui, H; Shozu, M; Usui, H | 1 |
| Guenova, ML; Hristoskova, RG; Petkova, NY; Raynov, JI | 1 |
| Nazha, B; Owonikoko, TK | 1 |
| Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE | 1 |
| Caballero, MD; Canales, M; de la Cruz, F; Domingo-Domenech, E; Garcia-Sanz, R; Gonzalez, AP; Gutierrez, A; Jimenez-Cabrera, S; Lopez, J; Martinez, C; Moreno, M; Pinana, JL; Rodriguez, A; Rodriguez, G; Rodriguez-Salazar, MJ; Sanchez-Gonzalez, B; Sureda, A | 1 |
| Hashizume, A; Hiruma, T; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Tatenuma, T; Umemoto, S; Yasui, M | 1 |
| Andión, M; Lassaletta, A; Lavarino, C; López-Pino, MA; Madero, L; Perez-Somarriba, M | 1 |
| Cao, K; Cao, P; Huang, C; Li, X; Liu, L; Tian, R; Wang, L; Zhu, H | 1 |
| Alsdorf, W; Bokemeyer, C; Oing, C; Seidel, C | 1 |
| Bishton, M; Campbell, R; Cheah, CY; Cochrane, T; De Mel Widanalage, S; Gilbertson, M; Hapgood, G; Hawkes, E; Hill, K; Johnston, A; Lee, HP; Manos, K; Nelson, N; Ng, M; Ng, ZY; Opat, S; Poon, M; Purtill, D; Ratnasingam, S; Ritchie, D; Schwarer, A; Seymour, J; Shorten, S; Sunny, T; Tam, C; Xin, L | 1 |
| Advani, AS; Caimi, P; Carew, J; Carraway, H; Chan, R; Cooper, B; de Lima, M; Elson, P; Gerds, A; Hamilton, B; Kalaycio, M; Little, J; Maciejewski, J; Malek, E; Miron, A; Mukherjee, S; Nazha, A; Pink, J; Sekeres, MA; Sobecks, R; Tomlinson, B; Unger, A; Visconte, V; Wei, W | 1 |
| Blajer-Olszewska, B; Chojnacki, T; Drozd-Sokołowska, J; Długosz-Danecka, M; Hus, I; Jurczak, W; Jurczyszyn, A; Puła, B; Raźny, M; Romejko-Jarosińska, J; Taszner, M | 1 |
| Arcari, A; Battistini, R; Bocci, G; Borza, PA; Caridi, M; Casaroli, I; Cox, MC; di Landro, F; Di Napoli, A; Fabbri, F; Marcheselli, L; Musuraca, G; Patti, C; Pelliccia, S; Tafuri, A | 1 |
| Nitta, H | 1 |
| Banavali, S; Devadas, SK | 1 |
| Auerbach, C; Cheron, R; Natarajan, E; Pashankar, F | 1 |
| Alapetite, C; Calaminus, G; Frappaz, D; Garrè, ML; Kortmann, R; Nicholson, JC; Patte, C; Ricardi, U; Saran, F; Worch, J | 1 |
| Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG | 1 |
| Jiang, SY; Karam, I; Khaira, M; Lee, CW; Schellenberg, D | 1 |
| Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
| Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Riccardi, R; Ridola, V; Rizzo, D; Ruggiero, A | 1 |
| Cai, ZM; Dong, P; Gui, YT; He, YY; Liu, ZW; Lv, ZJ; Wu, S; Yao, K; Zhou, FJ | 1 |
| Bembnista, E; Czyz, A; Dytfeld, D; Gil, L; Kazmierczak, M; Komarnicki, M; Kozlowska-Skrzypczak, M; Lojko-Dankowska, A; Matuszak, M; Nowicki, A | 1 |
| Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T | 1 |
| Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY | 1 |
| Calaminus, G; Friemann, V; Göbel, U; Kyrillopoulou, O; Leuschner, I; Matuschek, C; Mils, O; Rothe, K; Schaper, J; Schneider, DT; Schönberger, S; Wessalowski, R; Willers, R | 1 |
| Baek, HJ; Han, JW; Im, HJ; Kang, HJ; Koh, KN; Lee, SH; Park, HJ; Park, KD; Sung, KW | 1 |
| Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
| Baranzelli, MC; Corradini, N; Cropet, C; Fasola, S; Faure-Conter, C; Frappaz, D; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Rocourt, N; Rome, A; Thebaud, E; Vérité, C | 1 |
| Benigno, BB | 1 |
| Athanasopoulos, A; Daladimos, T; Kosmas, C; Papachrysanthou, T; Tsavaris, N; Vlachoyiannopoulos, PG | 1 |
| Liu, H; Shan, Y; Tian, YT; Wang, CF; Xie, YB; Xu, Q; Yuan, XH; Zhang, JW; Zhao, DB; Zhou, ZX | 1 |
| Go, A; Guo, R; Parthasarathy, M; Rodriguez, T; Smith, S; Sobol, U; Stiff, P; Vimr, R | 1 |
| Cunningham, D; Linch, DC; Lowry, L; Smith, P | 1 |
| Curtin, J; Downey, A; Edwards, S; Kwa, M; Muggia, F; Reich, E; Wallach, R | 1 |
| Allen, JC; Bendel, AE; Campigotto, F; Chi, SN; Chordas, CA; Comito, MA; Goldman, S; Hubbs, SM; Isakoff, MS; Khatib, ZA; Kieran, MW; Kondrat, L; Manley, PE; Neuberg, DS; Pan, WJ; Pietrantonio, JB; Robison, NJ; Rubin, JB; Turner, CD; Werger, AM; Zimmerman, MA | 1 |
| Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC | 1 |
| Hu, K; Li, L; Liu, H; Ma, M; Wang, H; Wang, M; Xu, Y; Zhang, L; Zhao, J; Zhong, W | 1 |
| Ansell, SM | 1 |
| Danielewicz, I; Leśniewski-Kmak, K; Małkowski, B; Zalewska, M; Zaucha, JM; Zaucha, R | 1 |
| Chang, WJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
| Burke, MJ; Gorman, MF; Gossai, N; Karras, NA; Patel, NJ; Verneris, MR | 1 |
| Díaz-Llopis, M; España-Gregori, E; Hernández-Martínez, P; Hervás-Ontiveros, A; Vera-Sempere, FJ | 1 |
| Bulanov, A; Fedyanin, M; Garin, A; Mosyakova, Y; Pokataev, I; Polockii, B; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
| Billmire, DF; Cullen, JW; Davis, M; Egler, RA; Frazier, AL; Krailo, M; Malogolowkin, MH; Olson, TA; Pashankar, F; Rescorla, FJ; Rodriguez-Galindo, C; Schlatter, MG; Villaluna, D | 1 |
| Cai, S; Shi, A; Yu, R; Zhu, G | 1 |
| Ardeshna, KM; Bird, A; Goldstone, AH; Kothari, J; Lambert, J; Linch, DC; Morris, E; Peggs, KS; Thomson, KJ; Virchis, AE | 1 |
| Asamura, H; Eba, J; Katayama, H; Kenmotsu, H; Niho, S; Shibata, T; Tamura, T; Tsuboi, M; Watanabe, S; Yamamoto, N | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Horikoshi, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Sawada, U; Sugitani, M; Takahashi, H; Takei, M; Takeuchi, J; Uchino, Y; Yagi, M | 1 |
| Boikos, SA; Brahmer, JR; Ettinger, DS; Forde, PM; Giaccone, G; Hann, CL; Hooker, CM; Illei, PB; Kelly, RJ; Petrini, I; Rudin, CM; Yang, SC | 1 |
| Agresti, B; Buccoliero, AM; Cardellicchio, S; de Martino, M; Fangusaro, J; Farina, S; Genitori, L; Sardi, I | 1 |
| Abruzzese, E; André, MP; Bardet, S; Bellei, M; Bouabdallah, R; Brice, P; Brusamolino, E; Casasnovas, RO; Federico, M; Fermé, C; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Lievens, Y; Lugtenburg, PJ; Meignan, M; Morschhauser, F; Olivier, P; Oumedaly, R; Raemaekers, JM; Raveloarivahy, T; Re, A; Sebban, CJ; Stamatoullas, A; van der Borght, T; van der Maazen, R; van Imhoff, G; Versari, A | 1 |
| Chang, H; Chen, X; Dai, Y; Dong, T; He, C; Ji, J; Li, J; Liu, T; Liu, W; Xiang, B | 1 |
| Behfar, M; Beiki, D; Eftekhari, M; Fallahi, B; Fard-Esfahani, A; Ghavamzadeh, A; Hamidieh, AA; Hosseini, AS; Paragomi, P; Shamshiri, A | 1 |
| Alig, SK; Aulinger, B; Dreyling, M; Rieger, CT; Seppi, B; Witkowski, L | 1 |
| Liu, SX; Wang, HY; Yan, JQ; Zhou, GY; Zou, J | 1 |
| Adlard, K; Alonzo, TA; Ballard, J; Gamis, AS; Gerbing, RB; Horton, TM; Howard, DS; Jenkins, G; Kelder, A; Moscow, JA; Perentesis, JP; Schuurhuis, GJ; Smith, FO | 1 |
| Cai, RQ; Chen, Y; Li, PF; Lu, SY; Sun, FF; Sun, XF; Wang, J; Wu, SX; Xia, YF; Yang, QY; Zhang, F; Zhen, ZJ; Zhu, J | 1 |
| Cavallin-Ståhl, E; Cohn-Cedermark, G; Dahl, O; Håkansson, U; Haugnes, HS; Klepp, OH; Langberg, CW; Laurell, A; Oldenburg, J; Söderström, K; Solberg, A; Ståhl, O; Stierner, U; Tandstad, T; Wahlquist, R; Wall, N | 1 |
| Ak, G; Akcay, M; Bayman, E; Etiz, D | 1 |
| Benson, C; Blay, JY; Dirksen, U; Gelderblom, H; Judson, I; Juergens, H; Placzke, J; Rasper, M; Rutkowski, P; van den Berg, H; van Maldegem, AM | 1 |
| Nagai, H | 1 |
| Belada, D; Smolej, L; Štěpánková, P; Sýkorová, A; Žák, P | 1 |
| Wang, W; Wang, Z; Xiao, X | 1 |
| Fey, MF; Karamitopoulou-Diamantis, E; Studer, UE; Thalmann, GN; Vidal, AD | 1 |
| Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C | 1 |
| Beck, JF; Ebinger, M; Feuchtinger, T; Furtwängler, R; Greil, J; Handgretinger, R; Illhardt, T; Klingebiel, T; Lang, P; Schlegel, PG; Schwarze, CP | 1 |
| Advani, RH; Agarwal-Hashmi, R; Donaldson, SS; Garfin, PM; Kharbanda, S; Link, MP; Luna-Fineman, S; Porteus, M; Weinberg, KI | 1 |
| Dragun, AE; Dunlap, NE; Jain, D; Meena, RA; Quillo, AR; Riley, EC; Shaughnessy, JN | 1 |
| Chen, CA; Chou, CY; Chou, HH; Ho, CM; Huang, YF; Kang, CY; Lin, H; Lu, CH; Wen, KC; Weng, CS; Yu, MH | 1 |
| Auliac, JB; Baize, N; Berard, H; Chouaid, C; Falchero, L; Gervais, R; Le Caer, H; Monnet, I; Olivero, G; Thomas, P | 1 |
| Brtnický, T; Fialová, A; Laštovička, J; Rob, L; Špíšek, R | 1 |
| Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M | 1 |
| Kadalayil, L; KhoshZaban, M; Kuku, S; Ledermann, J; Loddo, M; McCormack, M; Proctor, I | 1 |
| Du, XL; Li, HQ; Lu, CH; Pan, CX; Sheng, XG; Wang, C; Yin, YJ | 1 |
| Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
| Ichikawa, M; Kogure, Y; Kurokawa, M; Nakamura, F; Nannya, Y; Ueda, K; Yoshimi, A | 1 |
| de Melo, AC; Lopes da Silva, J; Luiz Renna, N; Paulino, E | 1 |
| Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z | 1 |
| Adachi, S; Fujino, H; Heike, T; Hiramatsu, H; Hori, T; Kato, I; Saida, S; Umeda, K; Watanabe, K; Yamada, T | 1 |
| Bongiovanni, A; Burgio, MA; Califano, R; Carloni, F; Casanova, C; Cavallo, G; Di Battista, M; Genestreti, G; Kazushige, W; Kenmotsu, H; Korkmaz, T; Metro, G; Roopa, K; Scarpi, E; Selcuk, S; Tiseo, M | 1 |
| Chang, J; Ding, H; Hao, SG; Hu, D; Li, ZC; Liu, LG; Ma, LY; Ma, YJ; Tao, R; Yan, Y; Zhang, WH | 1 |
| Harada, M; Inoue, A; Ishida, T; Kinoshita, I; Maemondo, M; Mori, Y; Morikawa, N; Nakagawa, T; Nukiwa, T; Oizumi, S; Saito, R; Sugawara, S; Suzuki, T; Taima, K; Watanabe, H | 1 |
| Chaopotong, P; Jaishuen, A; Kuljarusnont, S; Leelapatanadit, C; Therasakvichya, S | 1 |
| Bo, Q; Li, J; Li, K; Li, X; Liu, T; Tian, J; Wang, H | 1 |
| Asari, Y; Itoga, M; Kayaba, H; Morimoto, T; Nakamura, K; Okumura, K; Taima, K; Takanashi, S; Tanaka, H; Tanaka, Y | 1 |
| Fukuoka, K; Kuji, I; Matsutani, M; Nishikawa, R; Suzuki, T; Watanabe, Y; Yanagisawa, T | 1 |
| Alsina, M; Baz, RC; Fulp, W; Griffin, PT; Ho, VQ; Nishihori, T; Shain, KH | 1 |
| Brisse, H; Fasola, S; Mosseri, V; Orbach, D; Winter, S | 1 |
| Chang, TC; Chiang, YC; Hung, YC; Lai, HC; Lin, H; Liou, WS; Lu, CH; Sun, HD; Wang, KL; Wang, PH | 1 |
| Bassett, R; Champlin, R; Gulbis, AM; Holmberg, L; Jones, RB; Kingham, A; Ledesma, C; Margolin, K; Nieto, Y; Pagliaro, L; Tannir, N; Tu, SM | 1 |
| Hoffmann, L; Khalil, AA; Knap, MM; Moeller, DS; Winther-Larsen, A | 1 |
| Cosio, S; Gadducci, A; Lanfredini, N | 1 |
| Li, H; Liu, H; Qiu, L; Xiong, W; Yi, S; Zou, D | 1 |
| Ahn, SI; Lee, KY; Park, KM; Park, SY; Shin, WY | 1 |
| Baruchel, A; Bertrand, Y; Brethon, B; Cave, H; Galambrun, C; Gandemer, V; Leverger, G; Nelken, B; Plat, G; Rohrlich, P; Schmitt, C; Thomas, C; Vérité, C | 1 |
| Hashimoto, K; Kizaki, S; Matsui, H; Shozu, M; Usui, H | 1 |
| Dong, L; Du, J; Gao, X; Li, G; Li, Y; Song, Y; Sun, X; Wei, X; Xu, B | 1 |
| Benson, C; Jones, RL; Judson, I; Kasper, B; Khabra, K; Kollàr, A; Langer, R; Miah, A; Noujaim, J; Thway, K | 1 |
| Basu, B; Brenton, JD; Earl, HM; Gounaris, I; Hatcher, H; Iddawela, M; Parkinson, C; Pratt, J; Tan, LT | 1 |
| Beaven, AW; Diehl, LF | 1 |
| Fino, N; Gruber, L; Hurd, D; Kennedy, L; Lamar, ZS; Morris, BB; Palmer, J; Raetskaya-Solntseva, O; Vaidya, R; Zamkoff, K | 1 |
| Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D | 1 |
| Caballero, D; Canales, M; Dlouhy, I; González-Barca, E; López-Guillermo, A; Martín, A; Montes-Moreno, S; Ocio, EM; Redondo, AM; Salar, A | 1 |
| Bacon, CL; Bracken-Clarke, D; Browne, PV; Conneally, E; Daly, PA; Flynn, C; Gardiner, N; Hayden, PJ; Kennedy, MJ; Lee, G; McCaffrey, J; Ni Chonghaile, M; O'Donnell, DM; O'Kane, G; Power, D; Vandenberghe, E | 1 |
| Yang, YZ | 1 |
| Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Cheng, Y; Feng, J; Han, B; Hao, X; Hou, M; Hu, C; Li, W; Liu, X; Liu, Y; Luo, X; Qin, S; Sun, Y; Wan, H; Wang, J; Xia, Z; Xiu, Q; Zhang, H; Zhang, L; Zhu, Y | 1 |
| Buzzonetti, L; Cozza, R; De Ioris, MA; Natali, G; Romanzo, A; Valente, P | 1 |
| Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E | 1 |
| Bouffet, E; Bowers, DC; Foley, MA; Gill, SC; Horan, J; Jakacki, RI; Kieran, MW; Wang, J; Zacharoulis, S | 1 |
| Goto, K; Hida, T; Imamura, F; Kiura, K; Kozuki, T; Mori, K; Nakagawa, K; Nishio, M; Ohe, Y; Okamoto, H; Satouchi, M; Sawa, T; Seto, T; Shibata, T; Takahashi, T; Takeda, K; Tamura, T; Tanaka, H; Yoshimura, N | 1 |
| Arima, N; Fukunaga, A; Hyuga, M; Iwasaki, M; Kishimoto, W; Maesako, Y; Nakae, Y | 1 |
| Chen, Z; Hu, S | 1 |
| Beyer, J; Lorch, A | 1 |
| Dray, M; Mweempwa, A; Tan, A | 1 |
| Asao, T; Fujiwara, Y; Goto, Y; Horinouchi, H; Kanda, S; Kitahara, S; Nokihara, H; Ohe, Y; Okuma, HS; Sunami, K; Yamamoto, N | 1 |
| Ikegami, M; Matsutani, M; Mukasa, A; Nakao, Y; Saito, K; Saito, N; Shibahara, J; Takai, K; Takeshita, K; Tanaka, S; Yanagisawa, S | 1 |
| Abdalla, B; Alfaar, AS; Awad, M; Rashed, WM; Taha, H; Zekri, W | 1 |
| Aziz, HA; Berry, JL; Jubran, R; Kim, JW; Kogachi, K; McGovern, K; Murphree, AL; Zolfaghari, E | 1 |
| Deng, Z; Gu, Y; Li, J; Lin, S; Ma, J; Ma, W; Xu, J; Yao, X; Zhang, H | 1 |
| Grüllich, C; Grüner, M; Hadaschik, B; Hofheinz, RD; Jäger, D; Jentsch-Ullrich, K; Lasitschka, F; Zschäbitz, S | 1 |
| Camara, O; Keil, E; Klare, P; Lichtenegger, W; Oskay-Oezcelik, G; Paulenz, A; Sehouli, J; Sommer, H; Stauch, M; Stengel, D; Zeimet, AG | 1 |
| de Wilde, PC; Groot-Loonen, J; Hulsbergen-van der Kaa, C; Merkx, MA; Neven, J | 1 |
| Chung, SE; Ham, DI; Koo, HH; Sa, HS; Sung, KW; Yoo, KH | 1 |
| Chen, YB; Fu, WJ; Hou, J; Wang, DX; Xi, H; Yuan, ZG | 1 |
| Cohen, VM; Hungerford, JL; Kingston, J | 1 |
| Budning, A; Chan, HS; Dai, S; Dimaras, H; Doyle, J; Drake, J; Gallie, BL; Halliday, W; Héon, E | 1 |
| Arndt, CA; Hawkins, DS; Hoots, WK; Inwards, CY; Kleinerman, ES; Koshkina, NV; Morales-Arias, JA; Munsell, MF; Rodriguez, NI | 1 |
| Boyett, JM; Dhall, G; Dunkel, IJ; Finlay, JL; Gardner, SL; Goldman, S; Packer, RJ; Pollack, IF; Rosenblum, MK; Stanley, P; Wallace, D; Yates, AJ; Zimmerman, RA | 1 |
| Chi, HS; Jang, S; Kang, YA; Kim, DY; Kim, SH; Lee, JH; Lee, KH; Lee, SS; Lee, YS; Lim, SN; Park, CJ; Ryu, SG; Seol, M; Yun, SC | 1 |
| Bao, Y; Chen, M; Chen, YY; Gao, JM; He, H; Hu, X; Liu, Y; Poudel, S; Sun, ZW; Wang, WH; Wang, Y; Zhang, L; Zhuang, TT | 1 |
| Chamberlain, MC; Glantz, MJ | 1 |
| Arpaci, F; Ataergin, S; Beyzadeoglu, M; Komurcu, S; Oysul, K; Ozet, A; Ozturk, M; Solchaga, L; Surenkok, S; Turan, M | 1 |
| Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
| Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
| Abu-Rustum, NR; Aghajanian, C; Alektiar, K; Chi, DS; Diaz, JP; Konner, J; Leitao, MM; Park, KJ; Zhao, H; Zivanovic, O | 1 |
| Cao, Y; Feng, FZ; Wan, XR; Xiang, Y; Yang, XY | 1 |
| Hartzell, K; Leahey, A; Meadows, AT; Ramasubramanian, A; Shields, CL; Shields, JA; Thangappan, A | 1 |
| Cui, XZ; Hao, XS; Li, LF; Li, W; Liu, PF; Liu, XM; Qiu, LH; Wang, HQ; Zhang, HL | 1 |
| Albers, P; Dieckmann, KP; Fimmers, R; Hartmann, M; Heidenreich, A; Kliesch, S; Köhrmann, KU; Krege, S; Kwasny, P; Lehmann, J; Loy, V; Pechoel, M; Schmelz, H; Siener, R; Weissbach, L; Wittekind, C | 1 |
| Cho, GJ; Chung, JS; Joo, YD; Kim, KH; Kim, YS; Lee, WS; Shin, HJ; Shin, SH; Sohn, CH | 1 |
| Bremnes, RM; Cavallin-Stahl, E; Cohn-Cedermark, G; Dahl, O; Klepp, O; Langberg, C; Laurell, A; Solberg, A; Stierner, U; Tandstad, T; Wijkstrøm, H | 1 |
| Grodman, H; Kretschmar, C; Wolfe, L | 1 |
| Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R | 1 |
| Bairey, O; Lazar, AD; Shaklai, M; Shpilberg, O | 1 |
| Baud, M; Chouaïd, C; Febvre, M; Lebeau, B; Masanès, MJ | 1 |
| Ando, M; Fujiwara, Y; Hirata, T; Iwasa, S; Katsumata, N; Kouno, T; Nakano, E; Ono, M; Shimizu, C; Tamura, K; Yonemori, K; Yunokawa, M | 1 |
| Abe, H; Fukushima, T; Komatsu, F; Matsumoto, S; Nabeshima, K; Nomura, Y; Oshiro, S; Takano, K; Tsugu, H; Utsunomiya, H; Yanai, F | 1 |
| Ayan, I; Cicin, I; Eralp, Y; Guney, N; Kebudi, R; Saip, P; Topuz, E | 1 |
| Chekerov, R; Fotopoulou, C; Karavas, A; Lichtenegger, W; Sehouli, J; Trappe, R | 1 |
| Aristotelis, B; Georgios, P; Giannis, M; Ioannis, A; Konstantinos, S; Meletios-Athanasios, D; Nikolaos, A; Pantelis, P; Vassiliki, K | 1 |
| Adalberto, Bdel P; Aglietta, M; Aliberti, S; Berger, M; Biasin, E; Brach del Prever, A; Eleonora, B; Fagioli, F; Ferrari, S; Franca, F; Francesco, S; Giovanni, G; Grignani, G; Massimo, A; Massimo, B; Saglio, F; Sandra, A; Stefano, F | 1 |
| Cheng, AL; Kuo, SH; Lin, ZZ; Yang, SH | 1 |
| Aoki, T; Matsutani, M; Miyatake, S; Mizutani, T; Nojima, K; Nozaki, K; Okumura, R; Takagi, T; Takahashi, JA; Taki, W; Ueba, T; Yuba, Y | 1 |
| Ji, W; Lü, JM; Ou, GF; Ren, H; Wang, LH; Wang, XZ; Yin, WB; Zhou, ZM | 1 |
| Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
| Agarwal, R; Fisher, RA; Hancock, B; Lindsay, I; Nagai, Y; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wells, M; Wischnewsky, MB | 1 |
| Basu, S; Faber, LP; Kim, AW; Liptay, MJ; Miller, C; Milman, S; Warren, WH | 1 |
| Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, TJ; Lee, JH; Lee, JW | 1 |
| Ahn, YC; Cho, J; Eom, HS; Huh, J; Kang, KM; Kim, BS; Kim, CY; Kim, JS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Lee, GW; Lee, SW; Pyo, HR; Suh, C | 1 |
| Bigner, DD; Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, JE; McLendon, RE; Norfleet, J; Reardon, DA; Sampson, JH; Sathornsumetee, S; Vredenburgh, JJ | 1 |
| Leelahakorn, S; Manusirivithaya, S; Tangjitgamol, S; Thavaramara, T | 1 |
| Han, H; Hou, GL; Li, YH; Liu, ZW; Qin, ZK; Ye, YL; Zhang, XQ; Zhang, ZL; Zhou, FJ | 1 |
| Brown, PD; Buckner, JC; Jensen, AW; Laack, NN; Schomberg, PJ; Wetmore, CJ | 1 |
| Anderson, JR; Huh, WW; Raney, RB; Rodeberg, D; Teot, L; Yock, T | 1 |
| Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Shi, W | 1 |
| Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y | 1 |
| Choi, DR; Huh, J; Kim, S; Kim, SW; Lee, DH; Lee, JS; Lee, SW; Sohn, BS; Suh, C; Yoon, DH | 1 |
| Feng, FY; Liu, P; Qin, Y; Shi, YK; Xing, PY | 1 |
| Abdel-Rahman, S; Baur-Melnyk, A; Blay, JY; Daugaard, S; Dürr, HR; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Lindner, LH; Mansmann, U; Ploner, F; Reichardt, P; Salat, C; Schem, BC; Verweij, J; Vujaskovic, Z; Wendtner, CM; Wessalowski, R; Wust, P | 1 |
| Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A | 1 |
| Dupre, S; Francesconi, AB; Hughes, BG; Lickliter, JD; Martin, D; Matos, M; Wyld, DK | 1 |
| Aliev, MD; Chernov, IS; Machak, GN; Meluzova, OM; Polotskiĭ, BE | 1 |
| Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G | 1 |
| Chan, JK; Chen, LM; Cohen, JG; Kapp, DS; Osann, K; Sherman, AE; Shin, JY; Urban, R | 1 |
| Brown, E; Hebra, A; Hudspeth, M; Jenrette, J | 1 |
| García-Fernández, E; Pérez-Mies, B; Regojo Zapata, RM; Serrano, MN | 1 |
| Ben-Shachar, I; Benshushan, A; Kogan, L; Lavie, M; Mejia-Gomez, J; Shushan, A | 1 |
| Ainslie, J; Hui, AC; Seel, M; Stillie, AL | 1 |
| Alapetite, C; Baranzelli, MC; Ben-Hassel, M; Bernier, V; Bouffet, E; Brisse, H; Carrie, C; Cuilliere, JC; Frappaz, D; Gaboriaud, G; Habrand, JL; Patte, C; Raquin, MA; Thiesse, P | 1 |
| Gibbs, CP; Indelicato, DJ; Islam, S; Keole, SR; Lagmay, JP; Marcus, RB; Morris, CG; Scarborough, MT | 1 |
| Kewalramani, T; Maragulia, JC; Moskowitz, AJ; Moskowitz, CH; Vanak, JM; Yahalom, J; Zelenetz, AD | 1 |
| Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, J; McLendon, R; Peters, K; Reardon, DA; Rich, JN; Sampson, J; Threatt, S; Vredenburgh, JJ | 1 |
| Aurer, I; Baars, JW; Borchmann, P; DeJong, D; Diehl, V; Döhner, H; Engert, A; Fischer, T; Glossmann, J; Hansmann, ML; Josting, A; Metzner, B; Müller, H; Niederwieser, D; Raemaekers, J; Schäfer-Eckart, K; Schmitz, N; Smardova, L; Sureda, A | 1 |
| Berrak, SG; Liu, DD; Wolff, JE; Wrede, B | 1 |
| Bandopadhyay, G; Bowman, KJ; Braker, P; Coyle, B; Grundy, RG; Heath, R; Hussein, D; Jones, GD; Kerr, ID; Kumari, R; Lowe, J; Miller, S; Othman, R; Ottoman, R; Peet, A; Punjaruk, W; Rahman, R; Shaw, L; Storer, LC; Watson, S | 1 |
| Teh, TC; Wei, A | 1 |
| Fernandez, HF; George, TJ; Ho, VQ; Kharfan-Dabaja, MA; Komrokji, RS; Lancet, JE; List, AF; Pinilla-Ibarz, J; Price, SL; Wetzstein, GA | 1 |
| Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK | 1 |
| Feng, FZ; Wan, XR; Xiang, Y; Zhou, Y | 1 |
| Fishman, M; Kim, JW; Moshfeghi, D; Yau, JW | 1 |
| Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D | 1 |
| Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y | 1 |
| Fujimoto, T; Kumagai, S; Kurachi, H; Mizunuma, H; Nakahara, K; Nishiyama, H; Omi, H; Shoji, T; Sugiyama, T; Takano, T; Takatori, E; Tase, T; Yaegashi, N; Yokoyama, Y; Yoshizaki, A | 1 |
| Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
| Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Giesen, E; Kerst, JM; Mager, A; Rodenhuis, S; van Tinteren, H | 1 |
| Al-Barrak, J; Gilks, CB; Hoskins, P; Lau, H; Santos, JL; Swenerton, KD; Tinker, A | 1 |
| Hägglund, H; Karbach, H; Klimkowska, M; Machaczka, M; Nahi, H | 1 |
| Bridge, JA; Hori, T; Huang, D; Kanamori, M; Kimura, T; Suzuki, K; Yasuda, T | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
| Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C | 1 |
| Abdel-Hady Hemida, R; Abdel-Hady, el-S; El-Shamey, M; Gamal, A | 1 |
| Montes-Mollón, MÁ; Paz Moreno-Arrones, J | 1 |
| Bulanov, A; Burova, A; Fainshtein, I; Fedyanin, M; Figurin, K; Garin, A; Kanagavel, D; Sergeev, U; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
| Albers, P; Beyer, J; Lorch, A; Winter, C | 1 |
| Baumgart, M; Bertsch, HP; Haase, D; Kaune, KM; Mitteldorf, C; Neumann, C; Rosenwald, A; Schön, MP; Wulf, G | 1 |
| Bridger, GP; Broadley, K; Meagher, NS; Smee, RI; Williams, JR | 1 |
| Hur, SY; Ki, EY; Lee, CW; Lee, KH; Lee, SJ; Park, JS; Park, ST; Ryu, KS; Song, MJ | 1 |
| Ashcroft, L; Blackhall, F; Califano, R; Colaco, R; Faivre-Finn, C; Hulse, P; Lorigan, P; Sheikh, H; Taylor, P; Thatcher, N | 1 |
| Desjardins, A; Sampson, JH | 1 |
| Balashova, EE; Dashtiev, MI; Lokhov, PG | 1 |
| Furuya, T; Ikeda, T; Inoue, M; Kaneda, H; Koshinaga, T; Maebayashi, T; Masuko, T; Mugishima, H; Ohashi, K; Sugito, K; Yagasaki, H | 1 |
| Abdel Rahman, H; El Debawy, E; Ezzat, S; Mostafa, NE; Moussa, EA; Rayan, Ael R; Yones, A; Zekri, WZ | 1 |
| Bischof, M; Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Strauss, LG; Wuchter, P | 1 |
| Kivivuori, SM; Nygaard, R | 1 |
| Crump, M; Keating, A; Kuruvilla, J; Massey, C; Puig, N; Seshadri, T; Tsang, R; Villa, D | 1 |
| Avci, Z; Gursel, O; Kurekci, E; Malbora, B; Olgac, A; Ozbek, N | 1 |
| Abboud, CN; Cashen, AF; DiPersio, JF; Hladnik, LM; Kulkarni, S; McFarland, K; Motabi, IH; Rettig, MP; Stockerl-Goldstein, KE; Trinkaus, KM; Uy, GL; Vij, R; Westervelt, P | 1 |
| Bruessow, C; Gubler, J; Karrer, U; Pless, M | 1 |
| Daneshmand, S; Djaladat, H; Nichols, C | 1 |
| Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H | 1 |
| Iyoda, A; Jiang, SX; Kageyama, T; Masuda, N; Matsumoto, T; Nagashio, R; Ryuge, S; Saegusa, M; Sato, Y; Satoh, Y | 1 |
| Atchaneeyasakul, LO; Buaboonnam, J; Chiewvit, P; Sanpakit, K; Trinavarat, A | 1 |
| Lim, L; Powles, T; Rashid, S | 1 |
| Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
| Bowman, WP; Campana, D; Cao, X; Dahl, G; Inaba, H; Jenkins, L; Pounds, S; Pui, CH; Ribeiro, RC; Rubnitz, JE; Taub, JW | 1 |
| Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ | 1 |
| Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D | 1 |
| Colovic, M; Floros, KV; Gourgiotis, D; Pavlovic, S; Scorilas, A; Thomadaki, H; Tosic, N | 1 |
| Akyüz, C; Aydın, B; Büyükpamukçu, M; Kiratli, H; Poyraz, CB; Tarlan, B; Varan, A | 1 |
| Fu, K; Hao, XS; Hou, Y; Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL; Zhou, SY | 1 |
| Eijk, PP; Groenendijk, MR; Paul, MA; Postmus, PE; Smit, EF; Thunnissen, E; van de Wiel, MA; Ylstra, B | 1 |
| Egbert, SF; Hartemink, KJ; Koen, HJ; Marinus, PA; Paul, MA; Pieter, PE; Postmus, PE; Romane, SM; Schook, RM; Smit, EF | 1 |
| Han, TJ; Heo, DS; Kim, HJ; Kim, YW; Lee, SH; Wu, HG | 1 |
| Başaran, M; Bavbek, S; Ekenel, M; Keskin, S | 1 |
| Chan, JK; Cohen, JG; Kapp, DS | 1 |
| Bisogno, G; Carli, M; Casanova, M; Dall'Igna, P; De Ioris, MA; De Leonardis, F; De Salvo, GL; Ferrari, A; Manzitti, C; Meazza, C | 1 |
| Matsunaga, M; Miwa, K; Noguchi, T; Sasaki, Y | 1 |
| Chim, CS; Kim, SJ; Kim, WS; Kwong, YL; Leung, AY; Lim, ST; Tang, T; Tse, E | 1 |
| Abe, K; Matsumura, Y; Mizunuma, H; Tamura, R; Taniguchi, R; Yanagita, T; Yokoyama, Y | 1 |
| Cullen, M | 1 |
| Ceciliano, A; Chantada, GL; Dominguez, J; Fandino, AC; Millan, N; Schaiquevich, P; Taich, P; Villasante, F | 1 |
| Blaauwgeers, JL; Hartemink, KJ; Oosterhuis, JW; Paul, MA; Senan, S; Smit, EF; Thunnissen, E; Vos, CG | 1 |
| Buyukberber, S; Elkiran, ET; Gumusay, O; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Ozdemir, N; Ulas, A; Unal, O; Urakci, Z; Yaman, S | 1 |
| Beyer, J; Droz, JP; Fizazi, K; Hartmann, JT; Kramar, A; Lorch, A; Massard, C; Pico, JL; Rosti, G | 1 |
| Anderson, D; Greaves, P; Gribben, JG; Lillington, D; Lister, TA; Matthews, J; Montoto, S | 1 |
| Kitao, A; Matsumoto, K | 1 |
| Amato, B; Cardin, F; Lorenzetti, R; Martella, B; Militello, C; Terranova, C | 1 |
| Godoy, HE; Lele, SB; Odunsi, K; Olawaiye, AB; Rauh-Hain, JA; Shahzad, MM | 1 |
| Ansari, RH; Atkins, JN; Bogart, JA; Green, MR; Hodgson, LD; Kelley, MJ; Pang, H; Vokes, EE | 1 |
| Anderson, H; Björkholm, M; Delabie, J; Eriksson, M; Erlanson, M; Fluge, O; Fosså, A; Holte, H; Janes, R; Jerkeman, M; Jyrkkiö, S; Karjalainen-Lindsberg, ML; Kolstad, A; Leppä, S; Löfvenberg, E; Nordström, M; Ostenstad, B; Pedersen, LM; Sundström, C | 1 |
| Keskin, S; Taş, F; Vatansever, S | 1 |
| Akamatsu, H; Endo, M; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Nakamura, Y; Ono, A; Shukuya, T; Takahashi, T; Tsuya, A; Wakuda, K; Yamamoto, N | 1 |
| Badros, A; Barlogie, B; Morris, C; Tricot, G; Zangari, M | 1 |
| Antoniolli, SZ; Bassetto, MA; Beltrami, P; Curti, P; Maffei, N; Porcaro, AB | 1 |
| Chamberlain, MC | 7 |
| Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N | 1 |
| Büchler, T; Ferra, C; Grañena, A; Montanya, E; Virgili, N | 1 |
| Ikeda, H; Jokura, H; Kumabe, T; Kusaka, Y; Shirane, R; Yoshimoto, T | 1 |
| Adak, S; Herskovic, A; Johnson, DH; Keller, SM; Komaki, R; Livingston, RB; Marks, RS; Perry, MC; Schiller, JH; Vangel, MG; Wagner, H | 1 |
| Bolton, M; Copur, S; Frankforter, S; Fruehling, RM; Ledakis, P; Mleczko, KL; Muhvic, J; Norvell, M; Novinski, D; VanWie, E | 1 |
| Fujiyama, Y; Kanaya, H; Kim, P; Watanabe, K | 1 |
| Bornfeld, N; Havers, W; Heimann, H; Jurklies, C; Schueler, AO; Wieland, R | 1 |
| Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
| Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
| Beck, JD; Borkhardt, A; Creutzig, U; Harbott, J; Jacobs, U; Langer, T; Leis, T; Metzler, M; Rascher, W; Reichel, M; Reinhardt, D; Repp, R; Ritter, J; Schrappe, M; Stanulla, M; Viehmann, S | 1 |
| Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
| Benita-Weiss, M; Bushunow, P; Coyle, TE; Evans, B; Friedman, H; Korones, DN; Mechtler, L; Quinn, JA; Reardon, DA | 1 |
| Chung, HC; Jang, WI; Jeung, HC; Kim, BS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Shin, HJ; Sohn, JH | 1 |
| Badenoch, D; Berney, D; Nargund, V; Oliver, RT; Ong, J; Shamash, J | 1 |
| Chen, J; Gu, L; Pan, C; Tang, J; Xue, H; Zhao, H | 1 |
| Coldman, BJ; Fossella, FV; Glisson, BS; Komaki, R; Kurie, JM; Lee, JS; Lu, C; Palmer, JL; Pisters, KM; Shin, DM | 1 |
| Cowlishaw, D; McKendrick, JJ; Mead, GM | 1 |
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Metzner, B; Rick, O; Schleucher, N; Schmoll, HJ; Thomas, M | 1 |
| Demirci, H; Eagle, RC; Shields, CL; Shields, JA | 1 |
| Burdach, S; Dunst, J; Finke, R; Gadner, H; Göbel, U; Haase, R; Haerting, J; Juergens, H; Laws, HJ; Metzner, B; Meyer-Bahlburg, A; Pape, H; van Kaik, B; Wawer, A | 1 |
| Chelghoum, Y; Elhamri, M; Le, QH; Michallet, M; Revesz, D; Thomas, X | 1 |
| Eckardt, J; Green, M; Thatcher, N | 1 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Cater, J; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 1 |
| Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A | 1 |
| Ainslie, J; Hamilton, C; Harvey, J; Keller, J; Mackintosh, J; Poulsen, M; Rischin, D; Tripcony, L; Walpole, E | 1 |
| Saijo, N | 1 |
| Hammerschmidt, S; Pohlink, C; Rother, T; Wirtz, H | 1 |
| Göbel, U; Laws, HJ; Pape, H; Paulussen, M; van Kaick, B | 1 |
| Bacik, J; Bajorin, D; Bosl, GJ; Kondagunta, GV; Mariani, TV; Mazumdar, M; Motzer, RJ; Sheinfeld, J | 1 |
| Brunetto, AL; Leone, LD; Loss, JF; Santos, PP | 1 |
| Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K | 1 |
| Casak, S; Chantada, G; Dávila, MT; Fandiño, A; Manzitti, J; Raslawski, E; Schvartzman, E | 1 |
| Betticher, DC; Egli, F; Honegger, HP; Jacky, E; Jermann, M; Jost, LM; Kroner, T; Stahel, RA; Taverna, Ch | 1 |
| Qi, ST; Qiu, BH | 1 |
| Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
| Einhorn, LH; Look, KY; McClean, JW; Shaheen, M; Stender, MJ | 1 |
| Bilgin, T; Kara, HF; Ozan, H | 1 |
| Castellano, A; Cozza, R; De Laurentis, C; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
| Otis, CN; Powell, JL | 1 |
| Esfahani, JK; Gilani, MM; Moosavi, AS; Tehranian, A | 1 |
| Fisher, C; Hemmings, C | 1 |
| Ahmed, I; Kalaaji, AN; Markovic, SN; Shehan, JM | 1 |
| Campbell, AD; Cohn, SL; Duerst, R; Geissler, G; Haut, PR; Kalapurakal, J; Kletzel, M; Marymount, M; Morgan, E; Rademaker, A; Reynolds, M; Seshadri, R | 1 |
| Abramson, DH; Chantada, GL; Dunkel, IJ; Fandiño, AC | 1 |
| Goto, K; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsui, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Nokihara, H; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Sugiura, T; Tamura, T; Yamamoto, N; Yoshida, K | 1 |
| Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, XB; Pan, ZH; Peng, YL; Wang, W; Xia, ZJ | 1 |
| Behm, FG; Cheng, C; Gajjar, A; Hijiya, N; Jeha, S; Liu, W; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Zhang, Z | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 2 |
| Harbour, JW | 1 |
| Hadjeres, R; Lattouf, JB; Mc Cormack, M; Saad, F; Yelle, L | 1 |
| Bonazzi, C; Buda, A; Cantú, MG; Dell'Anna, T; Sacco, S; Urso, M | 1 |
| Covens, A; Gerulath, A; Merchandani, DE; Mirchandani, D; Osborne, R | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Erden, E; Geyik, PO; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yalçindağ, N | 1 |
| Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
| Fujii, Y; Kageyama, Y; Kihara, K; Kobayashi, T; Masuda, H; Tadokoro, M | 1 |
| Batchelor, AG; Liddington, MI; Rawlins, JM; Towns, G | 1 |
| Hatae, M; Nakamura, T; Onishi, Y | 1 |
| Fujimoto, N; Fujiwara, K; Hamazaki, S; Kiura, K; Kozuki, T; Mizobuchi, K; Shiomi, K; Tabata, M; Tanimoto, M; Ueoka, H | 1 |
| Allam, A; Bazarbashi, S; El Foudeh, M; El Hassan, I; El Weshi, A; Ezzat, A; Memon, M; Pai, C; Rahal, M; Raja, M | 1 |
| Bonci, E; Castello, MA; Clerico, A; Hadjistilianou, T; Ragni, G; Schiavetti, A | 1 |
| Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
| Bogart, J; Evans, L; Green, MR; Herndon, JE; McClay, EF; Seagren, SL; Watson, D | 1 |
| Hayama, M; Higashihara, M; Kajiwara, K; Khori, M; Niitsu, N; Tamaru, J | 1 |
| Engelholm, SA; Gronlund, B; Horvath, G; Mäenpää, J; Ridderheim, M | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
| Afshar, F; Besser, GM; Geddes, J; Plowman, PN; Shipley, J; Summersgill, B | 1 |
| Dong, M; Feng, FY; He, XH; Huang, DZ; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhang, P; Zhou, SY | 1 |
| Aamdal, S; Aasebø, U; Bremnes, RM; Kaasa, S; Sundstrøm, S | 1 |
| Ichinose, Y; Ishizuka, N; Kato, H; Suzuki, K; Tsuchiya, R; Watanabe, Y; Yasumitsu, T | 1 |
| Alcutt, D; Grogan, L; Morris, P; Nasser, Q; Razak, AR | 1 |
| Diehl, V; Dörken, B; Engert, A; Glossmann, JP; Josting, A; Kisro, J; Ko, Y; Mapara, M; Metzner, B; Nogova, L; Peters, N; Sieniawski, M; Staak, O | 1 |
| Billups, CA; Davidoff, AM; Fuller, CE; Krasin, MJ; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Crown, J; Fraser, I; Kennedy, J; Power, RE; Thornhill, JA | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Ness, S; Shelil, A; Shields, CL; Shields, JA | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Dunant, A; Le Chevalier, T; Pignon, JP | 1 |
| Botton, Sd; Chelghoum, Y; Dhedin, N; Dombret, H; Dreyfus, F; Elhamri, M; Fenaux, P; Guerci, A; Le, Q; Michallet, M; Pautas, C; Pigneux, A; Raffoux, E; Reman, O; Revel, Td; Thiebaut, A; Thomas, X; Travade, P; Troncy, J; Vekhoff, A | 1 |
| Nath, SV; Seymour, JF | 1 |
| Kara, B; Kara, IO; Paydas, S; Sahin, B | 1 |
| Bouffet, E; Foreman, N; Korones, DN; Smith, A | 1 |
| Hamilton, C; Harvey, J; Keller, J; Porter, I; Poulsen, MG; Rischin, D; Tripcony, L; Walpole, E | 1 |
| Aparicio, J; Arranz, JA; Barnadas, J; Dorta, J; García del Muro, X; Germà-Lluch, JR; Guma, J; Maroto, P; Paz-Ares, L; Terrassa, J | 1 |
| Aversa, S; Billio, A; Brunori, M; Candela, M; Centurioni, R; Chisesi, T; Congiu, AM; Contu, A; Crugnola, M; De Souza, C; Majolino, I; Marino, G; Nati, S; Olivieri, A; Patti, C; Porcellini, A; Rubagotti, A; Santini, G; Sertoli, MR; Spriano, M; Tedeschi, L; Vimercati, R | 1 |
| Basso, ME; Bertin, D; Gandola, L; Genitori, L; Giangaspero, F; Madon, E; Massimino, M; Mastrodicasa, L; Paglino, A; Perilongo, G; Ricardi, U; Sandri, A; Sardi, N; Todisco, L; Valentini, L | 1 |
| Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
| Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S | 1 |
| Ambrogi, V; Ferroni, P; Laudisi, A; Mariotti, S; Mineo, D; Mineo, TC; Pompeo, E; Roselli, M | 1 |
| Cloughesy, TF; Lai, A; Mischel, P; Nghiemphu, P; Pope, WB | 1 |
| Berzioli, C; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Paioli, A; Paioli, G; Palmerini, E; Scopece, L; Spagnolli, F | 1 |
| Benson, W; Bradstock, KF; Crombie, C; Gottlieb, D; Hertzberg, MS; Taper, J | 1 |
| Gisselbrecht, C; Hagberg, H | 1 |
| Bedano, PM; Bonnin, J; Einhorn, LH | 1 |
| Wan, X; Xiang, Y; Yang, J; Yang, X | 1 |
| Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y | 1 |
| Driver, D; Kilby, AM; McTiernan, A; Michelagnoli, MP; Whelan, JS | 1 |
| Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS | 1 |
| Dearnaley, DP; Gilbert, DC; Horwich, A; Huddart, RA; Nicholl, J; Norman, AR | 1 |
| Azuhata, T; Griffith, TS; Miller, M; Sandler, AD; Scott, D | 1 |
| An, R; Han, X; Wang, S; Xue, Y; Zhu, K | 1 |
| Bajciova, V; Kadlecova, V; Kepak, T; Mazanek, P; Mudry, P; Pavelka, Z; Sterba, J; Valik, D; Zitterbart, K | 1 |
| Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Debeljak, A; Kern, I; Korosec, P; Kosnik, M; Triller, N | 1 |
| Friere, J; Komarnicky, L; Mashayekhi, A; Shields, CL; Shields, JA; Sun, H; Uysal, Y | 1 |
| Fangusaro, J; Finlay, J; Rook, J; Rosser, T | 1 |
| Huh, J; Jeong, YP; Kim, S; Kim, SB; Kim, SW; Ko, OB; Koo, JE; Lee, D; Lee, JL; Park, SH; Suh, C | 1 |
| Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
| Feun, LG; Heros, D; Herrera, C; Landy, H; Marini, A; Markoe, A; Robles, C; Savaraj, N | 1 |
| Chang, YL; Chen, CK; Jou, ST; Lee, YC; Tseng, YT | 1 |
| Cicciarelli, N; Feuer, W; Murray, TG; Schefler, AC; Toledano, S | 1 |
| Huang, ZH; Ling, JY; Sun, XF; Xia, Y; Yang, QY; Zhen, ZJ | 1 |
| Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lu, TX; Xia, YF; Xian, CG; Zhang, YJ | 1 |
| Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F | 1 |
| Cheng, WW; Cho, WC; Law, SC; Ma, VW; Ngan, RK; Podust, VN; Yip, C; Yip, TT; Yip, V; Yiu, HH | 1 |
| Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
| Berthold, F; Hero, B; Klingebiel, T; Längler, A; Simon, T | 1 |
| Jeremić, B; Milićić, B | 1 |
| Cartner, M; Holley, A; Lipman, J | 1 |
| Atta, J; Chow, KU; Hoelzer, D; Martin, H; Mitrou, PS; Weidmann, E | 1 |
| Cheng, S; Evans, WK; Shepherd, FA; Stys-Norman, D | 1 |
| Benaroush, M; Blumenfeld, Z; Zuckerman, T | 1 |
| Batchelor, TT; Black, PM; Bradshaw, J; Chen-Plotkin, AS; Doherty, L; Drappatz, J; Folkman, J; Gigas, DC; Kesari, S; Kieran, M; Kracher, J; Laforme, A; Levy, B; Muzikansky, A; O'Neill, A; Ramakrishna, N; Schiff, D; Weiss, SE; Wen, PY | 1 |
| Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
| Berthold, F; Claviez, A; Frühwald, MC; Harnischmacher, U; Hero, B; Jorch, N; Längler, A; Simon, T | 1 |
| Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
| Chouaid, C; Gervais, R; Le Caer, H; Le Guen, Y; Paillotin, D | 1 |
| Drosik, K; Jankowska, R; Jassem, J; Konopa, K; Koralewski, P; Kowalski, D; Kozielski, J; Krzakowski, M; Olszewski, W; Orłowski, T; Ramlau, R; Reinfuss, M; Roszkowski, K; Wojtukiewicz, M | 1 |
| Chan, JK; Chan, WK; Epstein, RJ; Leong, CH; Liang, RH; Yau, T | 1 |
| Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R | 1 |
| Ang, LC; Dennis, KE; Fisher, BJ | 1 |
| Blancard, PS; Guigay, J; Jounieaux, V; Lher, P; Magois, E; Margery, J; Milleron, B | 1 |
| Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P | 1 |
| Abonour, R; Brames, MJ; Chamness, A; Einhorn, LH; Perkins, SM; Williams, SD | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Billalabeitia, EG; Carmona-Bayonas, A; Díaz, MP; Gómez, FI; Saura, HP; Soler, IO; Tafalla, MS | 1 |
| Fukao, M; Isogai, R; Kawada, A | 1 |
| Fujisawa, I; Kageyama, N; Kato, SF; Nakao, S; Ooyama, K; Seto, S; Ueba, T; Yamashita, K; Yorihuji, T | 1 |
| Al-Ali, HK; Niederwieser, D; Wittekind, C | 1 |
| Berthaud, P; Dick, G; Pein, F; Pinkerton, R; Pritchard-Jones, K; Vassal, G | 1 |
| Goldman, S; Greenwald, MJ; Mets, MB; Reitman, AJ; Seshadri, R; Strauss, LC; Weinstein, JL; Zage, PE; Zeid, JL | 1 |
| Albers, P; Langenkamp, S | 1 |
| Hosoi, H; Iehara, T; Iwai, N; Koizumi, M; Misawa, A; Miyaji, M; Nishimura, T; Sugimoto, T; Tokiwa, K; Tsuchiya, K; Yagyu, S; Yanagisawa, A | 1 |
| Bauditz, J; Lochs, H; Ventz, M | 1 |
| Hasumi, H; Izumi, K; Kanno, H; Mikata, K; Nagashima, Y; Osada, Y; Otai, J; Tsuchiya, F; Umemoto, S | 1 |
| Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
| Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR | 1 |
| Jiang, J; Kong, BH; Nan, FF; Wang, B; Yang, XS; Zhang, YZ | 1 |
| Billups, CA; Krasin, MJ; Liu, T; Navid, F; Rao, BN; Rodríguez-Galindo, C | 1 |
| Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M | 1 |
| Jain, S; Mandal, S; Varma, K | 1 |
| Bambach, B; Battiwalla, M; Benekli, M; Czuczman, MS; Hahn, T; Hernandez-Ilizaliturri, F; McCarthy, PL; Padmanabhan, S; Smiley, SL; Younis, T | 1 |
| Caballero, D; Canals, C; Finke, J; Goldstone, A; Hunter, A; Kienast, J; Kobbe, G; Kolb, HJ; Kyriakou, C; Metzner, B; Oberg, G; Reimer, P; Schmitz, N; Sureda, A; Theorin, N | 1 |
| Fujisawa, M; Hara, I; Kumano, M; Miyake, H; Muramaki, M; Takenaka, A | 1 |
| Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY | 1 |
| Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K | 1 |
| Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T | 1 |
| Coleman, M; Elstrom, R; Furman, R; George, P; Kaufman, TP; Leonard, JP; Martin, P; Niesvizky, R; Ruan, J | 1 |
| Casasnovas, O; Choquet, S; Dupriez, B; Fourme, E; Gisselbrecht, C; Hoang-Xuan, K; Jaccard, A; Janvier, M; Kolb, B; Leblond, V; Omuro, A; Sanson, M; Souleau, B; Soussain, C; Taillandier, L; Taksin, AL; Witz, F; Zini, JM | 1 |
| Bacon, C; Egerer, G; Freier, K; Hofele, CM; Thiele, OC | 1 |
| Lindsay, I; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wang, J | 1 |
| Albers, P; Dieckmann, KP; Fimmers, R; Hartmann, M; Heidenreich, A; Kliesch, S; Köhrmann, KU; Krege, S; Kwasny, P; Lehmann, J; Loy, V; Pechoel, M; Schmelz, HU; Siener, R; Weissbach, L; Wittekind, C | 1 |
| Hirose, S; Hojo, T; Ikeuchi, S; Isobe, Y; Kinoshita, T; Kubochi, K; Matsumoto, S; Sadako, AT; Shien, T; Terada, K | 1 |
| Bukowski, RM; Hewlett, JS; Livingston, RB; Montie, J; Mortimer, J | 1 |
| Denck, H; Karrer, K; Pridun, N; Zwintz, E | 1 |
| Bremer, K; Krischke, W; Niederle, N; Schmidt, CG; Seeber, S | 1 |
| Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Barrett, A; McElwain, TJ; Peckham, MJ; Taylor, RE | 1 |
| Blessing, JA; Delgado, G; Slayton, RE | 1 |
| Lokich, J | 1 |
| Castaigne, D; Culine, S; Droz, JP; Duvillard, P; Kattan, J; Leclere, J; Lhomme, C; Michel, G; Pico, J | 1 |
| Mukaiyama, T; Ogawa, M | 1 |
| Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
| Bagshawe, KD; Begent, RH; Brampton, M; Holden, L; Ledermann, JA; Newlands, ES; Rustin, GJ | 1 |
| Akakura, K; Akimoto, S; Masai, M; Ohki, T; Shimazaki, J | 1 |
| Hara, A; Kaku, Y; Nishimura, Y; Sakai, N; Yamada, H | 1 |
| Green, MR; Lilenbaum, RC; MacManus, DA | 1 |
| Matsutani, M; Miyoshi, A; Nagashima, C; Yoshizawa, H | 1 |
| Gastineau, DA; Hoagland, HC; Letendre, L; Noel, P; Solberg, LA; Tefferi, A | 1 |
| Elfenbein, GJ; Fields, KK; Perkins, JB | 1 |
| Chantarawiroj, P; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, EG; Tresukosol, D; Wharton, JT | 1 |
| Richel, DJ; Rodenhuis, S; Schornagel, JH; ten Bokkel Huinink, WW; van der Wall, E; Vlasveld, LT | 1 |
| Chamberlain, MC; Grafe, MR | 1 |
| Kobayashi, T; Matsutani, M; Nagai, H; Shitara, N; Sugita, K; Takakura, K; Tanaka, R; Yamada, H; Yamashita, J; Yoshida, J | 1 |
| Calderoni, A; Fey, MF; Kraft, R; Mazzucchelli, L; Sonntag, RW; Studer, UE | 1 |
| Bonnel, C; Catry-Thomas, I; Eghbali, H; Hoerni, B; Soubeyran, P | 1 |
| Ansari, R; Einhorn, LH; Faylona, EA; Gonin, R; Loehrer, PJ; Sandler, AB | 1 |
| Bajorin, DF; Bokemeyer, C; Bosl, GJ; Demetri, GD; Einhorn, LH; Kantoff, PW; Nichols, CR; Schmoll, HJ | 1 |
| Fujita, H; Ishizaki, T; Itoh, R; Okada, H; Yamamoto, T; Yasuda, J | 1 |
| Acimovic, L; Djuric, L; Jeremic, B; Shibamoto, Y | 1 |
| Einhorn, LH; Loehrer, PJ | 1 |
| Fossella, FV; Garden, AS; Glisson, BS; Hong, WK; Komaki, R; Murphy, WK; Oswald, MJ; Peters, LJ; Roth, JA; Shin, DM | 1 |
| Bender-Götze, C; Burdach, S; Ebell, W; Friedrich, W; Herrmann, F; Klingebiel, T; Koscielniak, E; Kremens, B; Schmid, H; Siegert, W | 1 |
| Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T | 1 |
| Hayot, M; Le Chevalier, T; Michel, FB; Pujol, JL; Rouanet, P | 1 |
| Douglass, EC; Jones, DP; Marina, NM; Meyer, WH; Pratt, CB; Wilimas, JA | 1 |
| de Wit, R; Logmans, A; Stoter, G; van den Gaast, A; van der Burg, ME; Verweij, J | 1 |
| Bowman, LC; Douglass, EC; Furman, WL; Hudson, M; Marina, NM; Meyer, WH; Pappo, A; Rodman, J; Santana, VM; Shema, SJ | 1 |
| Cabanillas, F; Rodriguez, MA | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E | 1 |
| Arriagada, R; Chomy, P; de Cremoux, H; Le Chevalier, T; Ruffié, P | 1 |
| Dreger, P; Gassmann, W; Glass, B; Haferlach, T; Horst, HA; Löffler, H; Ollech-Chwoyka, J; Schmitz, N; Suttorp, M | 1 |
| Earl, HM; Jones, A; Radford, JA; Smith, IE; Thatcher, N; Van Hoef, ME; Woll, PJ | 1 |
| Calvert, AH; Cantwell, BM; Chapman, F; Charlton, C; Gumbrell, L; Lind, MJ; Millward, MM; Proctor, M; Robinson, A; Simmons, D | 1 |
| Beddoe, AM; Cohen, CJ; Dottino, PR | 1 |
| Advani, SH; Iyer, RS; Kurkure, PA; Nair, CN; Pai, SK; Rao, SR | 1 |
| Clark, D; Kubica, R; Neidhart, JA; Pfile, J; Rinehart, J; Stidley, C | 1 |
| Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T | 1 |
| Bell, B; Bernstein, ML; Buchanan, GR; Devine, S; Dreyer, Z; Grier, H; Krischer, J; Kung, F; Land, V; Whitehead, VM | 1 |
| Abdel-Rahman, S; Bosse, D; Issels, RD; Jauch, KW; Schildberg, FW; Starck, M; Wilmanns, W | 1 |
| Itoh, A; Koyama, H; Miyata, K; Oguro, A; Okano, S; Sawai, K; Takeuchi, K; Tanaka, H; Taniguchi, H; Ueshima, Y | 1 |
| Brunat-Mentigny, M; Levitt, G; Margueritte, G; Pein, F; Pinkerton, R; Rubie, H; Sommelet, D; Thyss, A; Tournade, MF; Zücker, JM | 1 |
| Albain, KS; Crowley, JJ; Gandara, D; Griffin, B; Hutchins, L; Livingston, RB; O'Bryan, RM; Von Hoff, DD | 1 |
| Hiraki, S; Horiguchi, T; Kamei, H; Kiura, K; Kodani, T; Maeda, T; Ohnoshi, T; Shibayama, T; Tabata, M; Ueoka, H | 1 |
| Johnson, PW; Lister, TA; McCallum, P; Norton, AJ; Rohatiner, AZ; Sweetenham, JW | 1 |
| Dorigo, A; Kwan, YL; Mansberg, R | 1 |
| Golembe, B; Holbrook, CT; Homans, AC; Jaffe, N; Kung, FH; Nitschke, R; Pratt, CB; Schwenn, M; Strother, D; Vega, RA | 1 |
| Endo, Y; Hanasawa, K; Ishibashi, H; Kodama, M; Kurumi, Y; Sano, H; Shibata, J; Tani, T; Terata, N; Tsuji, K | 1 |
| Baker, TR; Hempling, RE; Piver, MS | 1 |
| Abfalter, E; Dapunt, O; Hetzel, H; Koza, A; Marth, C; Pointner, E; Windbichler, G; Zeimet, AG | 1 |
| Beuzeboc, P; Dieras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangie, T; Paraiso, D; Pierga, JY; Pouillart, P; Scholl, SM | 1 |
| Camitta, B; Holbrook, T; Krischer, J; Land, V; Mahoney, D; Sexauer, C; Steuber, CP; Weinstein, H | 1 |
| Berman, M; Blessing, JA; Currie, JL; McGehee, R; Soper, JT | 1 |
| Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H | 1 |
| Albrecht, W; Angel, K; Höltl, W; Pont, J; Postner, G; Sellner, F | 1 |
| Döhner, H; Flentje, M; Goldschmidt, H; Haas, R; Hunstein, W; Möhle, R; Moos, M; Murea, S; Wannenmacher, M; Witt, B | 1 |
| Kato, J; Yasumizu, T | 1 |
| Greco, FA; Hainsworth, JD | 1 |
| Dose, J; Freitag, K; Graeff, H; Jänicke, F; Kuhn, W; Pache, L; Schmalfeldt, B; Ulm, K | 1 |
| Ashley, DM; Duffner, PK; Friedman, HS; Gajjar, A; Kerby, T; Kun, L; Longee, D; Meier, L; Smith, S; Zalduondo, FM | 1 |
| Chiusolo, P; Di Mario, A; Leone, G; Micciulli, G; Salutari, P; Sica, S; Tommasi, M | 1 |
| Cain, JM; Collins, C; Figge, DC; Greer, BE; Livingston, RB; Petersdorf, S; Tamimi, HK | 1 |
| Hirao, Y; Okajima, E; Ozono, S | 1 |
| Abo, K; Hasegawa, H; Horita, K; Nakanishi, Y; Nakashima, T; Nishisaki, H; Oya, M; Yasutake, K; Yoshida, R | 1 |
| Chauvergne, J; Chinet-Charrot, P; Stöckle, E; Thomas, L; Toulouse, C | 1 |
| Bower, M; Fife, K; Holden, L; Newlands, ES; Paradinas, FJ; Rustin, GJ | 1 |
| Forsyth, P; Fulton, D; Urtasun, R | 1 |
| Kawamoto, K; Matsudaira, T; Matsumoto, M; Numa, Y; Shirayama, Y; Tsuchida, T; Yoshimura, K | 1 |
| Kearns, P; Majumdar, G; Partridge, F; Richardson, W; Wilcox, R | 1 |
| Anderson, JR; Armitage, JO; Bierman, PJ; Bishop, MR; Freeman, MB; Kessinger, A; Vose, JM | 1 |
| August, C; Bostrom, B; Boyett, JM; Cairo, M; Cohen, BH; Finlay, JL; Garvin, J; Geyer, JR; Goldman, S; Harris, RE; Packer, RJ; Sanders, J; Stanley, P; Wong, MC; Yates, AJ; Zimmerman, RA | 1 |
| Allen, JC; Siffert, J | 1 |
| Blessing, JA; Creasman, WT; Lewandowski, GS; Rose, PG; Webster, KD | 1 |
| Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN | 1 |
| Asano, K; Iizuka, N; Ohishi, Y; Onodera, S; Takeuchi, H; Tashiro, K; Wada, T; Yanada, S | 1 |
| Castello, MA; Gauthier, F; Oberlin, O; Schiavetti, A | 1 |
| Greenwald, MJ; Strauss, LC | 1 |
| Ameri, A; Delattre, JY; Monjour, A; Poisson, M; Ronchin, P; Sahmoud, T; Sanson, M | 1 |
| DeMonte, F; Eng, DY; Fuller, GN; Ginsberg, L; Jaeckle, K | 1 |
| Deppe, G; Tomlinson, MW; Treadwell, MC | 1 |
| Al-Saleh, E; Hoskins, PJ; Pike, JA; Swenerton, KD | 1 |
| Dearnaley, DP; Fisher, C; Horwich, A; Huddart, R; Husband, J; Nicholls, J; Norman, A; Paluchowska, B | 1 |
| Clemm, C; Gerl, A; Hentrich, M; Lamerz, R; Schmeller, N; Wilmanns, W | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Gize, G; Hromas, RA; Nichols, CR; Schacht, B | 1 |
| Ameri, A; Chauveinc, L; Chen, QM; Delattre, JY; Poisson, M | 1 |
| Balmaceda, C; Fetell, MR; Hesdorffer, C | 1 |
| Belasco, JB; Geyer, JR; Goldwein, JW; Herman-Liu, A; Molloy, PT; Needle, MN; Phillips, PC; Sutton, L | 1 |
| De Mulder, PH; de Wit, R; Oosterhof, GO; Tjan-Heijnen, VC | 1 |
| Oliver, RT | 1 |
| Carpenter, P; Lockwood, L; McCowage, GB; Shaw, PJ; Tiedemann, K; Toogood, I; White, L | 1 |
| Barişta, I; Başçil, N; Celik, I; Güllü, IH; Kars, A; Tekuzman, G; Yalçin, S | 1 |
| Carpenter, PA; Lockwood, L; McCowage, GB; Nayanar, V; Shaw, PJ; Tiedemann, K; Toogood, I; White, L | 1 |
| Athanassiou, A; Dimitriades, M; Kostopoulou, M; Mylonakis, A; Papadopoulou, M; Pectasides, D; Triantafillis, D; Varthalitis, J | 1 |
| Donnelly, E; Feun, LG; Lai, S; Lampidis, T; Savaraj, N; Solomon, J; Wu, CJ; Xu, R | 1 |
| Beuzeboc, P; Diéras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangié, T; Pierga, JY; Pouillart, P; Scholl, SM | 1 |
| Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
| Brewer, Y; Reboul, F; Taulelle, M; Vincent, P | 1 |
| Kimura, H; Momiki, S; Obata, S; Ogawa, T; Urabe, N; Yamaguchi, Y | 1 |
| Motzer, RJ; Sheinfeld, J; Xiao, H | 1 |
| Caldemeyer, K; Hanna, M; Heifetz, SA; Jakacki, RI; Jamison, C; Sender, L | 1 |
| Abella, E; Adams, PT; al-Katib, A; Dragovic, J; Du, W; Janakiraman, N; Karanes, C; Raman, SB; Ratanatharathorn, V; Sensenbrenner, L; Silver, SM; Uberti, J; Varterasian, M | 1 |
| Motzer, RJ | 1 |
| Ozols, RF | 2 |
| Chamberlain, MC; Kormanik, PA | 1 |
| de Potter, P; Hamada, A; Kheterpal, S; Meadows, AT; Needle, M; Shields, CL; Shields, JA | 1 |
| Akashi, K; Eto, T; Fujisaki, T; Gondo, H; Harada, M; Harada, N; Hayashi, S; Hirota, Y; Kinukawa, N; Makino, S; Matsuishi, E; Miyamoto, T; Mizuno, S; Murakawa, M; Nagafuji, K; Niho, Y; Ohno, Y; Okamura, T; Shibuya, T; Takamatsu, Y; Takenaka, K; Taniguchi, S; Tanimoto, K; Teshima, T; Yamasaki, K | 1 |
| Davis, BJ; Leibel, SA; Merchant, TE; Sheldon, JM | 1 |
| Allen, J; Bayer, L; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, J; Grovas, A; Halpern, S; Heller, G; Lindsley, K; Lyden, D; Mason, WP; Merchant, TE; O'Malley, B; Petriccione, MM; Puccetti, D; Rosenblum, M; Sands, S | 1 |
| Allen, JC; Bostrom, BC; Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Li, H; Rosenblum, M; Sender, LS; Yates, A | 1 |
| Cheng, X; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Oishi, T; Okada, M; Terakawa, N | 1 |
| Bilkay, BC; Burgut, R; Erkisi, M; Hazar, B; Seyrek, E | 1 |
| Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M | 1 |
| Ahuja, RK; Bonner, JA; Creagan, ET; Johnson, PA; Mailliard, JA; Marschke, RF; McGinnis, WL; Shaw, EG; Sloan, JA; Stella, PJ | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
| Buckley, J; Cairo, M; Feig, S; Harris, RE; Matthay, K; Ozkaynak, MF; Reynolds, CP; Seeger, RC; Villablanca, JG | 1 |
| Bishop, JF; Millward, MJ; Quinn, M; Rischin, D; Rome, R; Tebbutt, N; Toner, GC | 1 |
| Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M | 1 |
| De Leyn, PR; Demedts, MG; Deneffe, GJ; Lerut, TE; Lievens, YN; Nackaerts, KL; van der Schueren, E; Van Raemdonck, DE; Vansteenkiste, JF | 1 |
| Diehl, V; Engert, A; Josting, A; Kàtay, I; Rueffer, U; Tesch, H; Wickramanayake, PD; Winter, S | 1 |
| Cusidó, MT; García, A; Gonzalez, J; Jordá, B; Xercavins, J | 1 |
| Beppu, M; Chiba, T; Hiura, M; Kawakami, Y; Nogawa, T; Yokoyama, T | 1 |
| Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, JH; Goldman, S; Gollamudi, S; Guruangan, S; Merchant, TE; Rosenblum, M | 1 |
| Brader, KR; Burke, TW; Gershenson, DM; Levenback, CF; Morris, M | 1 |
| Blessing, JA; Rose, PG; Van Le, L; Waggoner, S | 1 |
| Barter, JF; Blessing, JA; Rose, PG; Soper, JT | 1 |
| Bergeron, S; Blazar, BR; Cairo, MS; Garrison, L; Krailo, MD; Reaman, GH; Secola, R; van de Ven, C; Weinthal, JA | 1 |
| Baranzelli, MC; Bergeron, C; Boutard, P; Frappaz, D; Gentet, JC; Hartmann, O; Michon, J; Pein, F; Philip, T; Quintana, E; Stephan, JL; Thyss, A; Tournade, MF; Valteau-Couanet, D; Vannier, JP; Zucker, JM | 1 |
| Fukuoka, M; Hirashima, T; Kawase, I; Kobayashi, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Sawaguchi, H; Tada, T; Takeda, K; Takifuji, N; Ushijima, S; Yana, T | 1 |
| Brockstein, BE; Haraf, DJ; Humerickhouse, R; Vokes, EE | 1 |
| Bernhardt, G; Czech, T; Fuiko, R; Hawliczek, G; Köller, U; Nirnberger, G; Pillwein, K; Slavc, I | 1 |
| Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F | 1 |
| Haga, N; Honda, K; Itoh, M; Muraki, O; Ohto, H; Tsuruya, Y; Yamaguchi, O | 1 |
| Cavalli, F; Ghielmini, M; Sanna, P; Van den Bosch, S | 1 |
| Haut, P; Kletzel, M; Marymount, M; Morgan, E; Pirich, L | 1 |
| Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S | 1 |
| Bundy, BN; Homesley, HD; Hurteau, JA; Roth, LM | 1 |
| Chen, LM; Elahi, R; Evans, R; Ignacio, L; Jacobs, R; Kozloff, M; Telfer, M; Vijayakumar, S | 1 |
| Harris, MB; Krischer, JP; Kung, FH | 1 |
| Böhlen, D; Borner, M; Fey, MF; Sonntag, RW; Studer, UE | 1 |
| Chao, HT; Chiang, H; Lai, CR; Lee, SD; Lee, WL; Ng, HT; Tseng, JY; Wang, PH; Yuan, CC | 1 |
| Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
| Alberts, DS; Delmore, JE; Fine, BA; Hannigan, EV; Liu, PY; Moore, DF; Poplin, EA; Potkul, RK; Wilczynski, S | 1 |
| Bauman, NM; Callaghan, EJ; McCulloch, TM; Victoria, L | 1 |
| Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K | 1 |
| Cheung, NK; Kramer, K; Kushner, BH | 1 |
| Belzer, K; Gaspar, LE; Kalemkerian, GP; Kraut, MJ; Valdivieso, M; Wozniak, AJ | 1 |
| Chastagner, P; Chouffai, Z; Couanet, D; Doireau, V; Grignon, Y; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Marchal, JC; Zerah, M | 1 |
| Aleksandrovic, J; Dagovic, A; Jeremic, B; Milicic, B; Milisavljevic, S; Nikolic, N; Radosavljevic-Asic, G; Shibamoto, Y | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
| Arakawa, S; Gohji, K; Gotoh, A; Hara, I; Hara, S; Kamidono, S; Miyake, H; Nakamura, I; Nomi, M; Oka, Y; Takechi, Y; Yamada, Y; Yamanaka, K | 1 |
| Eskens, FA; Pronk, L; Sillevis Smitt, PA; van den Bent, MJ; Vecht, CJ; Verweij, J | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Amistà, P; Brandes, AA; Carollo, C; Danieli, D; Gardiman, M; Guglielmi, B; Monfardini, S; Pinna, G; Turazzi, S; Volpin, L | 1 |
| Antman, KH; Balmaceda, C; Bruce, J; De LaPaz, R; Fetell, M; Hesdorffer, CS; Isaacson, S; Kaufman, E; Papadopoulos, KP; Savage, DG; Sisti, M; Troxel, A; Vahdat, LT | 1 |
| Johnson, DH | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
| Bogart, JA; Chung, CT; Ryu, S; Ungureanu, C; Zamkoff, KW | 1 |
| Holden, L; Mulholland, PJ; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
| Hong, W; Liu, L; Zhang, R | 1 |
| Brenner, B; Fenig, E; Katz, A; Njuguna, E; Schachter, J; Sulkes, A | 1 |
| Haselow, RE; Kirkwood, JM; Leaf, AN; Wolf, BC | 1 |
| Diehl, V; Draube, A; Engert, A; Josting, A; Reiser, M; Rueffer, U; Söhngen, D; Tesch, H; Wickramanayake, PD; Wolf, J | 1 |
| Allen, JC; Boyett, JM; Finlay, JL; Garvin, JH; Kobrinsky, NL; Packer, RJ; Shiminski-Maher, T; Stanley, P; Stewart, DJ | 1 |
| Gillespie, AM; Hancock, BW; Kumar, S | 1 |
| De Ruysscher, D; Vansteenkiste, J | 1 |
| Belasco, JB; Bunin, NJ; Lange, BJ; Leahey, AM; Meek, R; Scher, C | 1 |
| Cohen, KJ; Dubowy, RL; Fisher, PG; Korones, DN | 1 |
| Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H | 1 |
| Masuda, N; Negoro, S | 1 |
| Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
| Bonomi, PD; Kucuk, O; Pandya, KJ; Shevrin, DH | 1 |
| Hatano, H; Hatano, N; Kajita, Y; Kinoshita, T; Takasu, S; Usui, T; Wakabayashi, T; Yoshida, J | 1 |
| Adak, S; Brooks, BJ; Herskovic, A; Johnson, DH; Keller, SM; Komaki, R; Livingston, RB; Perry, MC; Wagner, H | 1 |
| Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
| Cheng, DK; Ng, TY; Ngan, HY; Wong, LC | 1 |
| Gallagher, CJ; Gupta, RK; Kelsey, S; Lister, TA; Newland, AC; O'Doherty, CA; Oliver, RT; Shamash, J | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G | 1 |
| Ames, MM; Bergeron, S; Blazar, BR; Bracho, F; Cairo, MS; Davenport, V; Krailo, MD; Liu-Mares, W; Panoskaltsis-Mortari, A; Reaman, GH; Reid, JM; Secola, R; Shen, V; van de Ven, C | 1 |
| Arai, H; Beppu, T; Hakozaki, S; Kubo, N; Ogawa, A; Suzuki, M; Wada, T; Yoshida, Y | 1 |
| Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G | 1 |
| Belani, CP; Calvo, AR | 1 |
| Chastagner, P; Couanet, D; Doz, F; Edan, C; Frappaz, D; Gambarelli, D; Gentet, JC; Grill, J; Habrand, JL; Kalifa, C; Le Deley, MC; Pierre-Kahn, A; Raquin, MA | 1 |
| Malik, IA | 1 |
| Bayer, R; Cairncross, G; Forsyth, P; Hu, W; Kaminer, L; Macdonald, D; Paleologos, N; Peterson, K; Ramsay, D; Rosenfeld, S; Salzman, D; Smith, A; Stewart, D; Swinnen, L | 1 |
| Chamberlain, MC; Glantz, MJ; Greenberg, HS; Wang, S | 1 |
| Cabeza, R; Hindenburg, A; Jeyakumar, A | 1 |
| Ashby, LS; Shapiro, WR | 1 |
| Gochi, A; Isozaki, H; Matsuno, T; Naomoto, Y; Shigemitsu, K; Tanaka, N | 1 |
| Beyer, J; Bokemeyer, C; Rick, O; Siegert, W | 1 |
| Munshi, HG; Pienta, KJ; Smith, DC | 1 |
| Ambrogi, V; Corsaro, V; Mineo, TC; Roselli, M | 1 |
| Fenton, LZ; Foreman, NK; Madden, JR; Partington, M; Weil, M; Winston, KR | 1 |
| Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
| Abdel-Rahman, S; Aydemir, U; Falk, MH; Hiddemann, W; Issels, RD; Kurze, V; Sauer, H; Wendtner, C | 1 |
| Abdel-Rahman, S; Baumert, J; Falk, MH; Hiddemann, W; Issels, RD; Krych, M; Santl, M; Wendtner, C | 1 |
| Dreger, P; Glass, B; Kuse, R; Schmitz, N; Seyfarth, B; Sonnen, R | 1 |
| Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
| Abonour, R; Cornetta, K; Gharpure, VS; Hanna, N; Loehrer, PJ | 1 |
| Alcaraz, L; Benboubker, L; Bergemer-Fouquet, AM; Calais, G; Colombat, P; Destrieux, C; Jan, M; Linassier, C | 1 |
| Bosset, JF; Egreteau, J; Madroszyk, A; Martin, L; Merrouche, Y; Queneau, PE | 1 |
| Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J | 1 |
| Jain, VK; Ogden, JL; Wilder, DD | 1 |
| Eguchi, T; Fujii, M; Kaiga, T; Kanamori, N; Kasakura, Y; Kobayashi, M; Kochi, M; Mochizuki, F; Tsuneda, Y; Wakabayashi, K | 1 |
| Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
| Cruz-Caudillo, JC; Liu, Z; Mira, JL | 1 |
| Klöss, M; Loeffler, M; Nguyen, TP; Pfreunschuh, M; Rübe, C; Trümper, L | 1 |
| Bai, P; Sun, J; Zhang, W | 1 |
| Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K | 1 |
| de Wit, R; Hilkens, PH; van den Bent, MJ; van der Burg, ME; van Putten, WL | 1 |
| Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
| Feng, J; Pang, L; Wang, X | 1 |
| Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M | 1 |
| Mahmoudi, M; Meyer, T; Nelstrop, AE; Rustin, GJ | 1 |
| Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
| Clamp, A; Jayson, GC | 1 |
| Beyer, J; Rick, O; Siegert, W | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Neri, N; Talavera, A | 1 |
| Demirci, H; Honavar, SG; Meadows, AT; Naduvilath, TJ; Shields, CL; Shields, JA | 1 |
| Aglietta, M; Bacci, G; Biasin, E; Brach del Prever, A; Fagioli, F; Ferrari, S; Madon, E; Palmero, A; Picci, P; Tienghi, A; Vassallo, E | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Daw, NC; Dome, JS; Kaste, SC; Meyer, WH; Pappo, AS; Pratt, CB; Rao, BN; Rodríguez-Galindo, C | 1 |
| Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V | 1 |
| Abu-Ghosh, AM; Cairo, MS; Davenport, V; Goldman, SC; Krailo, MD; Laver, JH; Morris, E; Reaman, GH; Slack, RS | 1 |
| Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
| Hensley, ML | 1 |
| Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Linfomi, MB; Luminari, S; Santini, G | 1 |
| Bergman, S; Creager, AJ; Geisinger, KR | 1 |
| Hartmann, D; Obrecht, JP; Stalder, GA | 1 |
| Gallagher, CJ; Oliver, RT; Ong, J; Raja, MA | 1 |
| Douek, E; Kingston, JE; Plowman, PN; Sebag-Montefiore, DJ | 1 |
| Ihara, H; Ikoma, F; Iwasaki, A; Mori, Y; Shima, H; Yabumoto, H; Yoshioka, M | 1 |
| Allard, P; Boita, F; Chastang, C; Fichet, D; Lebeau, B; Migueres, J | 1 |
| Collard, P; Francis, C; Rodenstein, DO; Weynants, P | 1 |
| Kudo, R; Sagae, S | 1 |
| Chang, TC; Hsu, JJ; Hsueh, S; Soong, YK | 1 |
| Saxman, S | 1 |
| Ishikawa, J; Nozaki, K; Okuno, S; Yamamoto, K | 1 |
| Band, PR; Connors, JM; Fetherstonhaugh, EM; Goldie, JH; Knowling, MA; Osoba, D | 1 |
| Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y | 1 |
| Gedikoğlu, G; Zülfikar, B | 1 |
| Finlay, JL; McElwain, M; Packer, RJ; Pons, MA; Puccetti, D; Walker, RW | 1 |
| Bowman, LC; Brenner, MK; Mirro, J; Santana, VM; Schell, MJ; Thompson, EI; Williams, R | 1 |
| Gore, M; Harding, M; Mansi, J; Meldrum, M; Milan, S; Perren, T; Selby, P; Treleavan, J; Viner, C; Zulian, G | 1 |
| Allen, J; Arenson, E; Helson, L; Pearce, J; Wisoff, J | 1 |
| Baglin, TP; Flavell, DJ; Flavell, SU; Lim, SH; Marcus, RE; Wimperis, JZ | 1 |
| Hirose, T; Koh, Y; Nakamura, T; Nakayoshi, A; Namatame, K; Ookubo, M; Sasaki, E; Shimada, K | 1 |
| Hamano, S; Izawa, I; Kokunai, T; Kudo, H; Kuwamura, K; Matsumoto, S; Sawa, H; Tamaki, N; Tatsumi, S | 1 |
| Ball, D; Bishop, J; Bull, C; Duval, P; Laidlaw, C; Matthews, J; Ngan, S | 1 |
| Eguchi, K; Goya, T; Kojima, A; Kondou, H; Ohe, Y; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T; Yamada, K | 1 |
| Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N | 1 |
| Levine, PA; Tabbara, IA | 1 |
| Ellerbroek, NA; Glisson, BS; Holoye, PY; Hong, WK; Komaki, R; Pang, AC; Roth, JA; Ryan, MB; Zatopek, NK | 1 |
| Loehrer, PJ | 1 |
| Höltl, W; Honetz, N; Julcher, H; Kienzer, H; Kosak, D; Machacek, E; Pont, J | 1 |
| Fukuoka, M; Ito, K; Kudoh, S; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N | 1 |
| McElwain, TJ; Meldrum, M; Milan, S; Perren, TJ; Selby, PJ | 1 |
| Dearnaley, DP; Harland, S; Hendry, WF; Horwich, A; Jay, G; Mason, M; Nicholls, J; Peckham, MJ | 1 |
| Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W | 1 |
| Coleman, RE; Cornbleet, MA; Howard, GC; Whillis, D | 1 |
| Hartlapp, JH; Weissbach, L | 1 |
| Jimi, S; Tsuruchi, N | 1 |
| Arita, N; Fujita, T; Hayakawa, T; Kubo, S; Miyawaki, Y; Nakagawa, H; Tsuruzono, K | 1 |
| Kredentser, DC | 1 |
| Imai, K; Kato, N; Kurita, M; Nakamura, T; Nakazawa, Y; Suzuki, K; Suzuki, T; Yamanaka, H | 1 |
| Gearhart, JP; Jeffs, RD; Leonard, MP | 1 |
| Hovi, L; Saarinen, UM; Sariola, H | 1 |
| Beckwith, JB; Mitsudo, S; Sparano, JA; Wiernik, PH | 1 |
| Baurmann, H; Henze, G; Kleiner, S; Schmid, H; Schwerdtfeger, R; Siegert, W; Zeiler, T | 1 |
| De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC; Pinto, MR; Testi, AM; Vegna, ML; Vignetti, M | 1 |
| Akiba, Y; Fujita, Y; Ikushima, Y; Ishida, S; Ohosaki, Y; Onodera, S; Sakai, E; Saotome, K; Shimizu, T; Tagaki, S | 1 |
| Cassano, WF; Dickson, N; Graham-Pole, J | 1 |
| Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 1 |
| Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD | 1 |
| Baruchel, A; Boiron, M; Brice, P; Ferme, C; Gerota, O; Gisselbrecht, C; Lepage, E; Marolleau, JP | 1 |
| Calvert, AH; Cantwell, BM; Lind, MJ; Millward, MJ | 1 |
| Bostrom, B; Christiansen, NP; Haake, RJ; Hurd, DD; Kim, TH; Lasky, LC; Levine, EG; McGlave, PB; Peterson, BA; Weisdorf, DJ | 1 |
| Björkholm, M; Ideström, K; Johansson, B; Kimby, E; Lindemalm, C; Merk, K; Osby, E | 1 |
| Nielsen, H | 1 |
| Archimbaud, E; Cordonnier, C; Devaux, Y; Dreyfus, F; Fenaux, P; Fiere, D; Jaubert, J; Leblond, V; Michallet, M; Travade, P | 1 |
| Calabró, F; Daniele, O; Fiore-Donati, L; Fiorentino, MV; Fornasiero, A; Ghiotto, C; Piazza, M; Rea, F | 1 |
| Brown, LD; Buckner, JC; Cascino, TL; Gerstner, JB; Krook, JE; O'Fallon, JR; Scheithauer, B; Westberg, MW; Wiesenfeld, M | 1 |
| Miura, K; Tsukada, T; Yuri, Y | 1 |
| Buzdar, A; Dunphy, F; Ewer, M; Holmes, F; Hortobagyi, G; Huan, S; Spitzer, G; Theriault, R; Wallerstein, R; Yau, J | 1 |
| Imamura, Y; Masuda, T; Matsushita, K; Ohno, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 1 |
| Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
| Beck, TM; Blasko, JC; Bukowski, RM; Crowley, JJ; Demattia, MD; Goodman, GE; Livingston, RB | 1 |
| Brandes, A; Cipriani, A; Favaretto, A; Festi, G; Fornasiero, A; Ghiotto, C; Paccagnella, A; Pappagallo, G; Vinante, O; Volpi, A | 1 |
| Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Strupp, J | 1 |
| Bonomi, P; Faber, LP; Hendrickson, FR; Kittle, CF; Lee, MS; Recine, D; Reddy, S; Rowland, K; Taylor, S; Warren, W | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Neuhaus, KL; Zeymer, U | 1 |
| Bosman, C; Ceccamea, A; Clerico, A; De Sanctis, S; Dominici, C; Thorel, MF | 1 |
| Chaffee, S; Falletta, JM; Friedman, HS; Kinney, TR; Kurtzberg, J; Ware, R | 1 |
| Broustet, A; Cony, P; Duclos, F; Marit, G; Puntous, M; Reiffers, J | 1 |
| Choi, KE; Daley, KM; Kaminer, LS; Larson, RA | 1 |
| de Góes, GM; Simon, SD; Srougi, M | 1 |
| Milani, A; Pasi, M; Piva, L; Pizzocaro, G; Salvioni, R; Zanoni, F | 1 |
| Milani, A; Piva, L; Pizzocaro, G; Salvioni, R; Zanoni, F | 1 |
| Evans, WK; Osoba, D; Rusthoven, JJ; Shepherd, FA; Turnbull, KA | 1 |
| Einhorn, LH | 1 |
| Clark, S; Donohue, JP; Einhorn, LH; Hui, S; Loehrer, PJ; Mandelbaum, I; Rowland, R; Seal, M; Ulbright, T; Williams, SD | 1 |
| Gershenson, DM; Kavanagh, JJ; Kline, RC; Larson, DM; Rutledge, FN; Wharton, JT | 1 |
| Finkel, HE; Griffing, GT; Hesketh, PJ; Larmon, SS; McCaffrey, RP; Melby, JC | 1 |
| Brada, M; Horwich, A; Peckham, MJ | 1 |
| Ban, Y; Ishihara, S; Iwata, H; Kanematsu, M; Komeda, H; Kuriyama, M; Oguchi, K; Takeuchi, T; Tanaka, T | 1 |
| Ihde, DC; Jacob, J; Linehan, WM; Ostchega, Y; Ozols, RF; Young, RC | 1 |
| Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
| Birch, R; Drasga, R; Einhorn, LH; Greco, FA; Loehrer, PJ; Omura, G; Williams, SD | 1 |
| Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D | 1 |
| Aapro, M; Bürki, K; Cavalli, F; Honegger, HP; Obrist, R | 1 |
| Clemm, C; Hartenstein, R; Sauer, H | 1 |
| Babayan, RK; Bulger, KN; Hesketh, PJ | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; Peracchia, G | 1 |
| Einhorn, LH; Loehrer, PJ; Williams, SD | 1 |
| Collins, C; Griffin, BR; Higano, CS; Keppen, MD; Livingston, RB; Miller, TP | 1 |
| Amiel, JL; Assouline, A; Azab, M; Bellet, D; Droz, JP; George, M; Michel, G; Piot, G; Theodore, C | 1 |
| Janic, G; Jassem, J; Karnicka-Młodkowska, H; Roszkowski, K; Rowińska-Zakrzewska, E; Szczepek, B; Traczyk, K; Zych, J | 1 |
| Birch, R; Einhorn, LH; Greco, FA; Hainsworth, JD; Williams, SD | 1 |
| Andoh, T; Hayashi, H; Kiyama, T; Miyamoto, M; Mizutani, T; Nishi, K; Nomura, T; Onda, M; Tokunaga, A; Umehara, M | 1 |
| Kanai, M; Kanno, M; Kobayashi, K; Kondo, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okafuji, K; Yoshida, T | 1 |
| Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 1 |
| Christiansen, NP; Kennedy, BJ | 1 |
| Armitage, JO; Dicke, KA; Hagemeister, FB; Horwitz, LJ; Jagannath, S; Kessinger, A; Smith, K; Tucker, SL; Vaughan, WP; Velasquez, WS | 1 |
| Almadrones, L; Chapman, D; Hakes, T; Hoskins, W; Jones, W; Markman, M; Ochoa, M; Reichman, B; Rubin, S; Saigo, P | 1 |
| Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P | 1 |
| Burgers, JK; Isaacs, JT; Marshall, FF | 1 |
| Alexanian, R; Barlogie, B; Cabanillas, F; Velasquez, WS | 1 |
| Kawashima, Y; Kobayashi, H | 1 |
| Aoyagi, H; Fujii, T; Izuo, M; Miyamoto, Y; Ohwada, S; Takeshita, M; Tanahasi, Y; Uchida, O | 1 |
| Evans, WK; Feld, R; MacCormick, R; Shepherd, FA; Yau, JC | 1 |
| Aroney, R; Bishop, JF; Gianoutsos, P; Kefford, R; Lee, J; Morstyn, G; Olver, IN; Raghavan, D; Stuart-Harris, R; Yuen, K | 1 |
| Coy, P; Evans, WK; Feld, R; Hodson, I; MacDonald, AS; Osoba, D; Pater, JL; Payne, DG | 1 |
| Akman, S; Carr, B; Doroshow, J; Leong, L; Margolin, K | 1 |
| Grieve, RJ; Harris, RI; Leyland, MJ; Patton, WN; Sangster, G | 1 |
| Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
| Bosl, GJ; Golbey, RB; Herr, H; MacDonald, G; Morse, M; Sogani, P; Vogelzang, N; Whitmore, W; Yagoda, A | 1 |
| Hilaris, BS; Natale, RB; Shank, B; Wittes, RE | 1 |
| Anderson, G; Chappell, AG; James, KW; Littlewood, TJ; Smith, AP | 1 |
| de Vries, EG; de Vries-Hospers, HG; Maas, A; Meinesz, AF; Mulder, NH; Mulder, PO; Postmus, PE; Sleijfer, DT | 1 |
| Choo, YC; Ma, HK; Wong, LC | 1 |
| Birch, R; Greco, FA; Sarma, P; Wolff, SN | 1 |
| Batist, G; Bunn, PA; Carney, DN; Cowan, KH; Gilliom, M; Ihde, DC; Veach, SR | 1 |
| Dixon, RH; Gottleib, RJ; Harvey, HA; Hoffman, SL; Lipton, A; Messeih, AA; Ricci, JA; Schweitzer, JM; Simmonds, MA; Stryker, JA | 1 |
| Kobayashi, O; Matsui, H; Sekiya, S; Takamizawa, H | 1 |
| Neville, AJ; Remick, SC; Willson, JK | 1 |
| Blessing, JA; Christopherson, WA; DiSaia, PJ; Slayton, RE | 1 |
| Forquer, R; Jarosinski, P; Kinsella, TJ; Magrath, I; Miser, JS; Triche, TJ; Tsokos, M; Wesley, R | 1 |
| Hovi, L; Mäkipernaa, A; Maunuksela, EL; Perkkiö, M; Rajantie, J; Siimes, MA; Wikström, S | 1 |
| Bennett, JM; Chang, AY; Rowe, JM | 1 |
| Carter, C; Winfield, DA | 1 |
| Gallurt Moreira, P; Millan Nuñez-Cortes, J; Senra Varela, A | 1 |
| Blume, KG; Forman, SJ | 1 |
| Barreras, L; Manten, H; Saldana, MJ; Sridhar, KS | 1 |
| Berry, DH; Brodeur, G; Dubowy, R; Hayes, FA; Krischer, J; Kung, F; Leventhal, B; Mahoney, D; Toledano, S | 1 |
| Appelbaum, FR; Buckner, CD | 1 |
| Beecham, J; Blessing, JA; DiSaia, PJ; Slayton, RE | 1 |
| Háber, J; Klener, P | 1 |
| Barnett, MJ; Ganesan, TS; Lister, TA; Man, T; Richards, MA; Waxman, JH; Wrigley, PF | 1 |
| Piver, MS | 1 |
| Jordaan, JP; Maxwell, AM | 1 |
| Raney, RB | 1 |
| Bozek, T; Finn, GP; Slevin, ML; Souhami, RL; Thomas, DG | 1 |
62 review(s) available for etoposide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Humans; Mitotane; Neoplasm Recurrence, Local | 2022 |
Quantitative evaluation of therapy options for relapsed/refractory diffuse large B-cell lymphoma: A model-based meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Rituximab; Transplantation, Autologous | 2023 |
Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review.
Topics: Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2023 |
Classic biphasic pulmonary blastoma: A case report and review of the literature from 2000 to 2022.
Topics: Adult; Etoposide; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Pulmonary Blastoma | 2023 |
Pediatric growing teratoma syndrome of the ovary: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Salpingo-oophorectomy; Syndrome; Teratoma | 2020 |
Current medical management of patients with poor-risk metastatic germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Taxoids; Testicular Neoplasms | 2018 |
Current pharmacotherapy for testicular germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Testicular Neoplasms | 2019 |
[MYC-associated B-cell lymphomas: pathophysiology and treatment].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2019 |
[Clinical analysis of 17 cases of gastric small cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Female; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2013 |
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Cytokines; Doxorubicin; Etoposide; Humans; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Syndrome; Treatment Outcome; Vincristine | 2015 |
Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Time Factors; Tomography, X-Ray Computed; Tonsillar Neoplasms; Treatment Outcome; Tumor Burden | 2014 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine | 2014 |
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids | 2014 |
Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
Topics: Antineoplastic Agents; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Incidence; Leukemia, Myeloid; Menopause, Premature; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Stillbirth; Uterine Neoplasms | 2015 |
[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2015 |
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2017 |
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy, Conformal; Surgical Procedures, Operative; Survival Rate; Vincristine; Young Adult | 2010 |
Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Registries; Uterine Cervical Neoplasms | 2010 |
Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epidural Neoplasms; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Molecular Diagnostic Techniques; Neoplasm Recurrence, Local; Sarcoma, Ewing; Thoracic Vertebrae; Vincristine | 2011 |
[High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Seminoma; Testicular Neoplasms; Young Adult | 2011 |
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Therapeutic Equipoise | 2012 |
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation | 2012 |
The management of small-cell carcinomas of the gynecologic tract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Genital Neoplasms, Female; Humans; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds | 2012 |
Presentation of two patients with malignant granulosa cell tumors, with a review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Granulosa Cell Tumor; Humans; Lymph Node Excision; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Review Literature as Topic; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Case Management; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Retroperitoneal Space; Retrospective Studies; Risk Factors; Salvage Therapy; Seminoma; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2002 |
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 2003 |
Progress in treatment of small-cell lung cancer: role of CPT-11.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Topoisomerase I Inhibitors | 2003 |
Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Skin Neoplasms; Stem Cell Transplantation; Vincristine | 2004 |
[Treatment of platinum-resistant ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials as Topic; DNA Damage; Docetaxel; Drug Resistance, Neoplasm; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Irinotecan; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Taxoids; Treatment Outcome | 2004 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials, Phase III as Topic; Etoposide; Female; Humans; Infusions, Intravenous; Lomustine; Lung Neoplasms; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ontario; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Topotecan | 2007 |
[Treatment strategy to obtain cure for recurrent advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Thiotepa | 1994 |
[Treatment for hormone-refractory or relapsing prostatic cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Survival Rate; Vinblastine | 1996 |
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 1996 |
Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Sertoli-Leydig Cell Tumor | 1997 |
Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Fatal Outcome; Germinoma; Humans; Life Tables; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Orchiectomy; Pelvic Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Teratocarcinoma; Testicular Neoplasms; Treatment Failure | 1997 |
Treatment in germ cell tumours: state of the art.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Seminoma; Survival Rate; Treatment Outcome; Urologic Neoplasms | 1997 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms | 1997 |
[Concomitant radiochemotherapy for locally advanced bronchial cancers: current results and prospects].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 1997 |
[Adjuvant chemotherapy of lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Vincristine | 1987 |
Adjuvant chemotherapy for testicular cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Compliance; Testicular Neoplasms | 1997 |
Future directions in the chemotherapy of ovarian cancer.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Europe; Female; Forecasting; Gemcitabine; Humans; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Time Factors; Topotecan; Vinblastine; Vinorelbine | 1997 |
Oral 5-FU alternatives for the treatment of head and neck cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Neoplasm Recurrence, Local; Tegafur; Uracil | 1998 |
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Prospective Studies; Risk Factors; Testicular Neoplasms; Time Factors; Vinblastine | 1999 |
Malignant triton tumor of the head and neck: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Lung Neoplasms; Magnetic Resonance Imaging; Mesna; Neoplasm Recurrence, Local; Neurilemmoma; Radiotherapy Dosage; Vincristine | 1999 |
Management of small cell lung cancer: current state of the art.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 1999 |
Oral etoposide for the treatment of recurrent ovarian cancer.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1999 |
Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2000 |
Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Taxoids; Teniposide; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Adult medulloblastoma: multiagent chemotherapy.
Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid Shunts; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Hematologic Diseases; Humans; Infratentorial Neoplasms; Life Tables; Lomustine; Male; Medulloblastoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine | 2001 |
Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms | 2001 |
Salvage chemotherapy in relapsed germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Testicular Neoplasms; Vinblastine | 2001 |
[Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Glioma; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Transplantation, Autologous | 2001 |
Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2001 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
Epithelial ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Practice Guidelines as Topic; Tamoxifen; Taxoids; Topotecan; Vinblastine; Vinorelbine | 2002 |
Salvage therapy in recurrent testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1992 |
Salvage therapy in recurrent germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Transplantation, Autologous | 1991 |
Cancer of the testis: a new paradigm.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Teratoma; Testicular Neoplasms; Vinblastine | 1986 |
[New combination chemotherapy in refractory rhabdomyosarcoma of the prostate: a case report and review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Peplomycin; Peptichemio; Prednisone; Prostatic Neoplasms; Rhabdomyosarcoma; Vincristine | 1987 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
303 trial(s) available for etoposide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Pregnancy; Vincristine | 2022 |
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.
Topics: Bendamustine Hydrochloride; Cytarabine; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Multiple Myeloma; Neoplasm Recurrence, Local; Transplantation, Autologous | 2022 |
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Phthalazines; Piperazines; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma | 2022 |
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 2022 |
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Lymphoma; Neoplasm Recurrence, Local; Treatment Outcome | 2022 |
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Etoposide; Humans; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prospective Studies | 2022 |
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Child; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Prednisone; Treatment Outcome; Vincristine | 2022 |
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prospective Studies; Proteasome Endopeptidase Complex; Rituximab | 2023 |
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Disease Progression; Etoposide; Humans; Immunotherapy; Irinotecan; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Small Cell Lung Carcinoma | 2023 |
Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Humans; Lymphoma, AIDS-Related; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Safety; Survival Rate; Transplantation, Autologous | 2020 |
Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Sweden; Treatment Outcome | 2020 |
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Vincristine; Young Adult | 2020 |
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine | 2020 |
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Carboplatin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 2021 |
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles | 2021 |
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2021 |
Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial.
Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Indazoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progression-Free Survival; Pyrimidines; Quality of Life; Sulfonamides | 2021 |
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy | 2022 |
Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection - A 13-year follow-up analysis of a phas
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Young Adult | 2021 |
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Co
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Cytarabine; Etoposide; Female; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Treatment Outcome; Young Adult | 2017 |
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Panobinostat; Survival Rate; Thrombocytopenia; Treatment Outcome; Young Adult | 2018 |
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Cost-Benefit Analysis; Etoposide; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Quality-Adjusted Life Years; Small Cell Lung Carcinoma; Survival Rate; Topotecan | 2018 |
Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma.
Topics: Administration, Metronomic; Adult; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Survival Rate; Vinblastine | 2017 |
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Everolimus; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult | 2018 |
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Young Adult | 2018 |
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction | 2018 |
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prednisone; Progression-Free Survival; Salvage Therapy; Transplantation, Autologous; Young Adult | 2019 |
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Patient Safety; Remission Induction; Salvage Therapy; Treatment Outcome | 2019 |
Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Survival Rate; Tamoxifen; Young Adult | 2019 |
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Temozolomide | 2013 |
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate | 2013 |
Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2013 |
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Fenofibrate; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Neovascularization, Pathologic; Prognosis; Prospective Studies; Pyrazoles; Sulfonamides; Survival Rate; Thalidomide; Young Adult | 2014 |
Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Vincristine; Young Adult | 2014 |
A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Disease-Free Survival; Etoposide; Female; Humans; Incidence; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Survival Analysis; Treatment Outcome | 2014 |
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine; Young Adult | 2014 |
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Pyrazines; Rabbits; Salvage Therapy; Treatment Outcome; Young Adult | 2014 |
Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Time Factors | 2014 |
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Time; Young Adult | 2015 |
Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vincristine | 2015 |
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cell Cycle; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2015 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; United States; Young Adult | 2015 |
Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Small Cell Lung Carcinoma; Survival Rate | 2015 |
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).
Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Child; Child, Preschool; Clofarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Young Adult | 2016 |
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Treatment Outcome; Young Adult | 2016 |
[Clinical Efficacy Comparison between CHOPE Regimen alone and It Combined with Thalidomide for Relapsed and Refractory Non-Hodgkin's Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lactate Dehydrogenases; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Prednisone; Survival Rate; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2016 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; China; Cisplatin; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma | 2016 |
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous | 2016 |
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Erlotinib Hydrochloride; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Treatment Outcome; Young Adult | 2016 |
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Topotecan | 2016 |
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Internationality; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prevalence; Risk Factors; Salvage Therapy; Survival Analysis | 2016 |
Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Deoxycytidine; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Proportional Hazards Models; Quality of Life; Survival Rate; Topotecan; Treatment Outcome | 2008 |
[Bortezomib-based combination therapy for relapsed or refractory multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cisplatin; Constipation; Cyclophosphamide; Dexamethasone; Dizziness; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Pyrazines; Thalidomide; Treatment Outcome | 2008 |
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2009 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2008 |
[Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retroperitoneal Space; Testicular Neoplasms | 2009 |
Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2009 |
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Tegafur; Uracil | 2009 |
Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma | 2010 |
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Topotecan; Venous Thromboembolism | 2009 |
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma | 2009 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2010 |
Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate; Treatment Outcome | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Republic of Korea; Risk Assessment; Time Factors; Treatment Outcome; Young Adult | 2009 |
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
Topics: Administration, Oral; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Failure; Vascular Endothelial Growth Factor A | 2009 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Neoplasm Recurrence, Local; Quality of Life; Radiotherapy; Salvage Therapy; Thiotepa; Young Adult | 2010 |
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2011 |
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retroperitoneal Neoplasms; Sarcoma; Survival Rate; Young Adult | 2010 |
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome | 2010 |
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Follow-Up Studies; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult | 2010 |
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide | 2011 |
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis | 2010 |
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2011 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Retrospective Studies; Salvage Therapy; Survival Rate; Teratoma; Treatment Outcome; Young Adult | 2011 |
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Thorax | 2012 |
Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neuroblastoma; Salvage Therapy; Treatment Outcome | 2011 |
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2011 |
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cyclams; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Receptors, CXCR4; Remission Induction; Salvage Therapy; Survival Rate; Young Adult | 2012 |
Treatment outcome in older patients with childhood acute myeloid leukemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Transplantation, Autologous; Young Adult | 2012 |
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Survival; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2013 |
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemoradiotherapy; Cisplatin; Confidence Intervals; Dehydration; Disease-Free Survival; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Small Cell Lung Carcinoma | 2013 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult | 2013 |
Salvage chemotherapy for recurrent spinal cord ependymona.
Topics: Administration, Oral; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Cord Neoplasms; Thrombocytopenia; Treatment Outcome; Weight Loss | 2002 |
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sex Factors; Survival | 2002 |
Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Survival Rate | 2002 |
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Temozolomide; Treatment Outcome | 2003 |
Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Analysis | 2003 |
A homoharringtonine-based regimen for childhood acute myelogenous leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cytarabine; Disease-Free Survival; Etoposide; Female; Harringtonines; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2003 |
A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Topotecan | 2003 |
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis; Prospective Studies; Treatment Outcome | 2003 |
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Salvage Therapy; Survival Rate | 2003 |
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiation Oncology; Risk Factors; Skin Neoplasms; Societies, Medical; Survival Rate | 2003 |
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retroperitoneal Space; Retrospective Studies; Survival Rate; Testicular Neoplasms | 2004 |
Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Child; Child, Preschool; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Survival Rate; Treatment Outcome | 2004 |
Results of a prospective study for the treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Idarubicin; Infant; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Optic Nerve Neoplasms; Prospective Studies; Retinoblastoma; Risk Factors; Scleral Diseases; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Analysis | 2004 |
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Palliative Care; Temozolomide; Topotecan; Treatment Outcome | 2004 |
Lack of activity of oral etoposide for relapsed intraocular retinoblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Pilot Projects; Retinal Neoplasms; Retinoblastoma | 2004 |
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2004 |
Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neoplasm Recurrence, Local; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Vincristine | 2004 |
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Vincristine | 2004 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Tamoxifen | 2005 |
Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Heart Diseases; Humans; Lymphoma, Follicular; Male; Middle Aged; Natriuretic Peptide, Brain; Neoplasm Recurrence, Local; Prednisone; Receptors, IgG; Remission Induction; Rituximab; Salvage Therapy; Troponin T; Vincristine | 2005 |
Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Administration Schedule; Etoposide; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Taxoids; Topotecan | 2005 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cross-Over Studies; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Health Status; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Treatment Outcome; Vincristine | 2005 |
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Care; Proportional Hazards Models; Survival Analysis; Treatment Outcome | 2005 |
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Treatment Outcome | 2005 |
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Epidemiologic Methods; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiotherapy Dosage; Skin Neoplasms | 2006 |
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Rate; Vincristine | 2005 |
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Treatment Outcome | 2006 |
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2006 |
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Fluorouracil; Glioma; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Treatment Outcome; Vincristine | 2006 |
Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study.
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms; Pilot Projects; Pyrazoles; Sulfonamides; Temozolomide; Treatment Outcome; Tretinoin | 2006 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Analysis; Treatment Failure | 2006 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Surveys; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Risk Factors; Survival Rate; Vincristine | 2007 |
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Tomography, X-Ray Computed | 2007 |
Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Treatment Outcome | 2007 |
Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Retrospective Studies | 2007 |
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyrazoles; Sulfonamides; Thalidomide | 2007 |
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Treatment Outcome | 2007 |
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
[Randomised phase II study evaluating oral combination chemotherapy (CCNU, cyclophosphamide, etoposide) and intravenous chemotherapy as second-line treatment for relapsed small cell bronchial carcinoma (Trial GFPC0501)].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Health Resources; Humans; Injections, Intravenous; Lomustine; Neoplasm Recurrence, Local; Quality of Life; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2007 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2007 |
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome | 2007 |
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Disease Progression; Etoposide; Eye Enucleation; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity | 2008 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome | 2008 |
Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure | 2008 |
The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local | 2008 |
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2008 |
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa | 2008 |
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms | 2008 |
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Reoperation; Survival Rate; Vinblastine | 1994 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
Chemotherapy for endocrine-therapy-refractory prostate cancer.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Estrogens; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Vincristine | 1994 |
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia | 1995 |
Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Pilot Projects; Reoperation; Salvage Therapy; Thiotepa | 1995 |
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy | 1995 |
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy | 1995 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis | 1995 |
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Recombinant Proteins; Vinblastine | 1995 |
Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Time Factors | 1995 |
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Treatment Failure; Vincristine | 1995 |
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Infant; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Radiotherapy, High-Energy; Remission Induction; Survival Rate | 1994 |
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1994 |
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Survivors; Time Factors; Treatment Failure | 1994 |
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Thrombocytopenia | 1994 |
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis | 1994 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure | 1994 |
Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome | 1993 |
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1993 |
Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome | 1993 |
Multiple cycles of dose-intensive cyclophosphamide, etoposide, and cisplatinum (DICEP) produce durable responses in refractory non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Drug Resistance; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome | 1994 |
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Child; Drug Tolerance; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid; Mesna; Neoplasm Recurrence, Local; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Urinary Tract | 1993 |
Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
Topics: Adolescent; Adult; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Treatment Outcome; Wilms Tumor | 1993 |
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ethylnitrosourea; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thiotepa; Vincristine | 1993 |
Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1993 |
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local | 1993 |
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Mesna; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome | 1993 |
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1996 |
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local | 1996 |
Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Etoposide; Female; Humans; Hydroxyurea; Middle Aged; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Neoplasms | 1996 |
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1996 |
Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate; Testicular Neoplasms; Treatment Outcome | 1996 |
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Diseases; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Clinical trial of daily low-dose oral etoposide for patients with residual or recurrent cancer of the ovary or uterus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Remission Induction; Uterine Neoplasms | 1995 |
Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Remission Induction | 1995 |
-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome | 1996 |
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Drug Resistance; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate | 1996 |
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 1996 |
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms | 1996 |
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Survival Rate | 1996 |
Contemporary chemotherapy issues for children with brainstem gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Dose-Response Relationship, Drug; Etoposide; Glioma; Humans; Neoplasm Recurrence, Local; Thiotepa; Vincristine | 1996 |
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Administration, Oral; Cohort Studies; Endometrial Neoplasms; Etoposide; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Thrombocytopenia; Time Factors | 1996 |
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Glioma; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Survival Rate; Tomography, X-Ray Computed | 1996 |
Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1997 |
Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Treatment Outcome | 1997 |
Recurrent cerebellar gliomas: salvage therapy with oral etoposide.
Topics: Adolescent; Alopecia; Antineoplastic Agents, Phytogenic; Astrocytoma; Cerebellar Neoplasms; Child; Child, Preschool; Diarrhea; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis | 1997 |
Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thiotepa | 1997 |
Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Neoplasms; Treatment Outcome | 1997 |
Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Time Factors | 1997 |
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Vincristine | 1997 |
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Survival Analysis; Vincristine | 1997 |
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1997 |
Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Survival Analysis; Treatment Failure | 1997 |
Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Carmustine; Cause of Death; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 1997 |
Chronic oral VP-16 for recurrent medulloblastoma.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Time Factors | 1997 |
Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Diseases; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Vitreous Body | 1997 |
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Leukocyte Count; Life Tables; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Proportional Hazards Models; Prospective Studies; Remission Induction; Treatment Outcome | 1997 |
Refractory breast cancer: a comparison of two different chemotherapy regimens.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission Induction; Turkey | 1997 |
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 1998 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis; Transplantation, Autologous | 1998 |
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Confidence Intervals; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1998 |
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Thoracotomy | 1998 |
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; Treatment Outcome | 1998 |
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1998 |
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1998 |
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1998 |
Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Uterine Neoplasms | 1998 |
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer G
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carboplatin; Child; Child, Preschool; Cytokines; Drug Tolerance; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Interleukin-3; Length of Stay; Neoplasm Recurrence, Local; Neoplasms; Recombinant Fusion Proteins | 1998 |
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulosa Cell Tumor; Humans; Indiana; Middle Aged; Neoplasm Recurrence, Local; New York; North Carolina; Ovarian Neoplasms; Prospective Studies; Reoperation; Sex Cord-Gonadal Stromal Tumors; Treatment Outcome | 1999 |
Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Analysis; Time Factors | 1999 |
Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Salvage Therapy | 1999 |
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Prospective Studies; Risk Factors; Testicular Neoplasms; Time Factors; Vinblastine | 1999 |
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms | 1999 |
Oral etoposide for refractory and relapsed neuroblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Treatment Outcome | 1999 |
Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Thorax; Treatment Outcome | 1999 |
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Follow-Up Studies; Glioma; Humans; Infant; Neoplasm Recurrence, Local; Procarbazine; Spinal Cord Neoplasms; Vincristine | 1999 |
Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy; Survival Rate; Yugoslavia | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Outcome | 1999 |
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Survival Analysis; Thiotepa; Treatment Outcome | 1999 |
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385).
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease Progression; Etoposide; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Sample Size; Thyroid Hormones; Thyroid Neoplasms; Treatment Outcome | 2000 |
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2000 |
Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Mannitol; Neoplasm Recurrence, Local; Survival Analysis; Treatment Failure | 1999 |
Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Injections, Spinal; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 2000 |
[Combination of irinotecan hydrochloride and etoposide for treatment of refractory or relapsed small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2000 |
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Diarrhea; Disease Progression; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Remission Induction; Survival Rate | 2000 |
[Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2000 |
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk; Survival Analysis | 2000 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Taxoids | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a h
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Infusions, Intravenous; Interleukin-6; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Recombinant Proteins | 2001 |
A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Survival Analysis; Treatment Outcome | 2000 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2001 |
Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Angiography; Cisplatin; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2001 |
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progression; Disease-Free Survival; Estramustine; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2001 |
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies | 2001 |
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2001 |
A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Growth Substances; Humans; Hydro-Lyases; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 2001 |
[FLEP therapy for advanced and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate | 2001 |
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Germany; Humans; Life Tables; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
[Combination chemotherapy of uterine sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Mitolactol; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Retrospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms | 2000 |
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Survival Analysis | 2002 |
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine | 2001 |
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Outcome; Vincristine; Vitreous Body | 2002 |
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Remission Induction; Survival Analysis; Transplantation, Autologous | 2002 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Etoposide for recurrent spinal cord ependymoma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Recurrence, Local; Spinal Cord Neoplasms | 2002 |
Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Wilms Tumor | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 2002 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; France; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging | 1992 |
Results of adjuvant chemotherapy for invasive uroepithelial cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1992 |
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Growth Disorders; Hematologic Diseases; Humans; Infant; Intellectual Disability; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nervous System Diseases; Radiation Injuries; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1992 |
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Thrombocytopenia | 1992 |
Small-cell carcinoma of the head and neck. A novel treatment regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiotherapy Dosage; Remission Induction; Tongue Neoplasms; Vincristine | 1991 |
A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and t
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Child; Drug Evaluation; Drug Resistance; Etoposide; Genetic Markers; Genetic Vectors; Humans; Informed Consent; Kanamycin Kinase; Neomycin; Neoplasm Recurrence, Local; Neuroblastoma; Phosphotransferases; Recombinant Proteins; Research Design; Transduction, Genetic; Transplantation, Autologous | 1991 |
A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of stage D neuroblastoma in first remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Child; Drug Evaluation; Drug Resistance; Etoposide; Genetic Markers; Genetic Vectors; Humans; Informed Consent; Kanamycin Kinase; Neomycin; Neoplasm Recurrence, Local; Neuroblastoma; Phosphotransferases; Recombinant Proteins; Research Design; Transduction, Genetic; Transplantation, Autologous | 1991 |
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Remission Induction; Sperm Count; Survival Rate; Testicular Neoplasms | 1991 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine | 1991 |
Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Retroperitoneal Space; Testicular Neoplasms; Vinblastine | 1991 |
BAVC regimen in CR AML patients.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cytarabine; Etoposide; Follow-Up Studies; Graft Survival; Humans; Infant; Italy; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Transplantation, Autologous | 1991 |
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies | 1991 |
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis | 1991 |
Chemotherapy for invasive thymoma. A 13-year experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Thymoma; Thymus Neoplasms; Vincristine | 1991 |
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local | 1990 |
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncolo
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Remission Induction; Survival Analysis; Vincristine | 1990 |
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Cancer of the testis: a new paradigm.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Teratoma; Testicular Neoplasms; Vinblastine | 1986 |
A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Pulmonary Fibrosis; Random Allocation; Vinblastine | 1988 |
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Costs and Cost Analysis; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Random Allocation; Time Factors | 1989 |
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local | 1989 |
[Evaluation of the second line of treatment of patients with small cell carcinoma of the lung].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1989 |
Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pulmonary Fibrosis; Retroperitoneal Neoplasms; Testicular Neoplasms | 1985 |
Combination chemotherapy with etoposide and 5-fluorouracil in advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms | 1989 |
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies | 1989 |
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Deglutition Disorders; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Dosage; Random Allocation; Vincristine | 1988 |
Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Topics: Carcinoma, Small Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation | 1986 |
Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Vincristine | 1987 |
Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1987 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
575 other study(ies) available for etoposide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2021 |
BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2021 |
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms | 2022 |
Management of a Primary Retroperitoneal Yolk Sac Tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Retroperitoneal Neoplasms | 2021 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Neoplasm Recurrence, Local; Transplantation Conditioning; Transplantation, Autologous | 2022 |
Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Seminoma; Testicular Neoplasms | 2022 |
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Neutrophils; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2022 |
High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Transplantation, Autologous | 2022 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |
Intensive Multimodal Therapy Combined With Long-term Temozolomide and Etoposide Treatment for Recurrent Osteosarcoma to the Liver and Stomach.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Etoposide; Humans; Liver; Neoplasm Recurrence, Local; Osteosarcoma; Stomach; Temozolomide | 2022 |
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Etoposide; Humans; Irinotecan; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Retrospective Studies | 2022 |
Successful multidisciplinary management of an asymptomatic gastrosplenic fistula in a diffuse large B cell lymphoma patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fistula; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Splenectomy; Vincristine | 2022 |
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Depsipeptides; Etoposide; Humans; Ifosfamide; Ki-1 Antigen; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy | 2022 |
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Recurrence, Local; Prospective Studies; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2022 |
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma; Salvage Therapy | 2022 |
Smart salvage treatment for Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Nivolumab; Salvage Therapy | 2022 |
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Toripalimab and anlotinib as a maintenance treatment for extensive-stage small-cell lung cancer: a case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Indoles; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Quinolines; Small Cell Lung Carcinoma | 2022 |
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
Lymph node metastasis as the initial symptom of a germ cell tumor in an adult: A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2022 |
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Prognosis; Retrospective Studies | 2022 |
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Small Cell Lung Carcinoma | 2022 |
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
Topics: Aged; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; ErbB Receptors; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local | 2022 |
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
Topics: Cyclophosphamide; Cytarabine; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Intensity-Modulated; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation | 2022 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Rituximab; Thalidomide; Treatment Outcome | 2023 |
Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Etoposide; Female; HMGB1 Protein; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Vincristine | 2023 |
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms | 2023 |
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine | 2023 |
Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations.
Topics: Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Repressor Proteins; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2023 |
High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Child; Child, Preschool; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2023 |
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
Topics: Animals; Etoposide; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Mice; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Platinum; Proto-Oncogene Proteins c-myc; Small Cell Lung Carcinoma | 2023 |
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Retrospective Studies; Rituximab | 2023 |
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis | 2023 |
Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report.
Topics: Aged; Carcinoma, Small Cell; Cisplatin; Colonic Neoplasms; Etoposide; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local | 2023 |
Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2023 |
Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2020 |
Primary neuroendocrine carcinoma of the brain.
Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Ventriculoperitoneal Shunt | 2019 |
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Time Factors; United States; Vincristine | 2019 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Transplantation, Autologous; Treatment Outcome | 2019 |
Malignant Sex Cord-Stromal Tumor, Not Otherwise Specified, Harboring FOXL2, p53, and TERT Promoter Mutations: Report of a Case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Forkhead Box Protein L2; Granulosa Cells; Humans; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Promoter Regions, Genetic; Sex Cord-Gonadal Stromal Tumors; Tumor Suppressor Protein p53 | 2020 |
Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Hemophagocytic relapsed intramedullary plasmacytoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2020 |
Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis.
Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Celecoxib; Cyclophosphamide; Drug Therapy; Etoposide; Female; Humans; Indazoles; India; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Pyrimidines; Recurrence; Sulfonamides | 2019 |
Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia.
Topics: Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Humans; Infant; Lymphocyte Transfusion; Male; Neoplasm Recurrence, Local; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies | 2021 |
Zero, Some Chemotherapy Game in Early-Stage Germ Cell Tumors.
Topics: Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2020 |
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; DNA Mismatch Repair; Etoposide; Humans; Male; Microsatellite Instability; Middle Aged; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Remission Induction | 2020 |
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy | 2020 |
Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Rete Testis; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Spain; Testicular Neoplasms; Treatment Outcome; Watchful Waiting | 2021 |
Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Temozolomide; Young Adult | 2020 |
Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vinblastine | 2020 |
[A Case of Primary Mediastinal Seminoma Showing Local Increase in Residual Tumor after Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Mediastinum; Neoplasm Recurrence, Local; Neoplasm, Residual; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Japan; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Rhabdomyosarcoma, Alveolar | 2020 |
[A Case of Metachronous Testicular Tumor Developing Twenty Years after Treatment of Retroperitoneal Extragonadal Germ Cell Tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms | 2020 |
Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Humans; Lymph Nodes; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Treatment Outcome | 2020 |
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Fluorescein Angiography; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Ultrasonography; Vincristine | 2020 |
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytoreduction Surgical Procedures; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Hypercalcemia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Ovary; Prospective Studies; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2020 |
Duodenal Obstruction Caused by the Long-term Recurrence of Appendiceal Goblet Cell Carcinoid.
Topics: Adult; Antineoplastic Agents; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cisplatin; Colectomy; Duodenal Obstruction; Etoposide; Humans; Intestinal Neoplasms; Japan; Male; Neoplasm Recurrence, Local; Treatment Outcome | 2020 |
Characteristics and outcome of patients with relapsed/refractory Hodgkin lymphoma following front-line escalated BEACOPP-based chemotherapy: a report from the Australasian Lymphoma Alliance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2020 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
Carboplatin plus etoposide or topotecan for small-cell lung cancer.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Topotecan | 2020 |
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Transplantation, Homologous; Vidarabine | 2021 |
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
Topics: Administration, Metronomic; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Organic Chemicals; Prednisone; Progression-Free Survival; Prospective Studies; Vinorelbine | 2020 |
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Topotecan | 2020 |
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' reply.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Topotecan | 2020 |
[Analysis of Relevant Factors of Refractory and Relapse DLBCL Treated by Rituximab Combined with CHOP/EPOCH Regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2020 |
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Germinal Center; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Progression-Free Survival; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2021 |
Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Craniospinal Irradiation; Etoposide; Female; Hearing Loss; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous | 2020 |
DECC (dexamethasone, etoposide, chlorambucil, lomustine) as an oral chemotherapy regimen in relapsed and refractory diffuse large B-cell lymphoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dexamethasone; Etoposide; Female; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local | 2021 |
[IEAC versus CEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for lymphoma: analysis of efficacy and safety in 106 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Recurrence, Local; Retrospective Studies; Transplantation, Autologous | 2020 |
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Humans; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2021 |
Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re-induction chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2021 |
Adaptive Radiation Therapy for Intact Thymoma: An Illustrative Report.
Topics: Adult; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Thymoma | 2021 |
A combinatorial drug screen in PDX-derived primary rhabdomyosarcoma cells identifies the NOXA - BCL-XL/MCL-1 balance as target for re-sensitization to first-line therapy in recurrent tumors.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; bcl-X Protein; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2; Rhabdomyosarcoma; Sulfonamides; Xenograft Model Antitumor Assays | 2021 |
Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy | 2021 |
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Vincristine; Young Adult | 2022 |
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.
Topics: Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.
Topics: Animals; Apoptosis; Bone Marrow Cells; Drug Resistance, Neoplasm; Etoposide; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Gene-Environment Interaction; Humans; Mesenchymal Stem Cells; Mice; Neoplasm Recurrence, Local; Neuroblastoma; Receptors, Lysosphingolipid; RNA, Small Interfering; Sphingosine-1-Phosphate Receptors; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Premedication; Retreatment; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2017 |
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Extremities; Humans; Ifosfamide; Infant; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Retrospective Studies; Sarcoma, Ewing; Treatment Failure | 2017 |
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; International Agencies; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Survival Rate; Testicular Neoplasms; Young Adult | 2017 |
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Case-Control Studies; Cytarabine; Diarrhea; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2018 |
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Health Status; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia | 2018 |
Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Heart Neoplasms; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Plasmacytoma; Positron-Emission Tomography | 2018 |
Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organs at Risk; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Vinblastine; Young Adult | 2018 |
DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cyclophosphamide; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Progression-Free Survival | 2018 |
Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
Topics: Brachytherapy; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Pelvis; Radiotherapy Dosage; Republic of Korea; Uterine Cervical Neoplasms | 2018 |
Long-term survival in recurrent adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bangladesh; Chronic Disease; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Mitotane; Neoplasm Recurrence, Local; Prognosis; Time Factors; Treatment Outcome | 2019 |
R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2018 |
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Drug Resistance, Neoplasm; Drug Substitution; ErbB Receptors; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Small Cell Lung Carcinoma | 2018 |
Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Japan; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gastrectomy; Gastroscopy; Histiocytic Sarcoma; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Recurrence, Local; Prednisolone; Retroperitoneal Space; Salvage Therapy; Stomach Neoplasms; Tomography, X-Ray Computed; Vincristine | 2018 |
The clinical conundrum of managing relapsed small cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan | 2019 |
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine | 2019 |
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Liposarcoma; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Pneumonectomy; Retroperitoneal Neoplasms; Surgical Procedures, Operative; Thoracoscopy; Time Factors; Treatment Outcome | 2018 |
Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Etoposide; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local | 2019 |
[Clinical observation for NAPD regimen in the treatment of 67 cases of recurrent refractory non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2019 |
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Induction Chemotherapy; International Cooperation; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2019 |
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Poland; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous | 2019 |
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Organic Chemicals; Prognosis; Prospective Studies; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Irinotecan; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction | 2020 |
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for pat
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; International Agencies; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2013 |
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2015 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; China; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Infant; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retrospective Studies; Risk Factors; Testicular Neoplasms; Treatment Outcome; Young Adult | 2013 |
Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Transplantation, Autologous; Young Adult | 2013 |
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Retrospective Studies; Salvage Therapy; Vincristine; Young Adult | 2013 |
Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Myeloid Cells; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2013 |
Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous; Young Adult | 2013 |
Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Treatment Outcome | 2014 |
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Failure; Vincristine | 2013 |
Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystadenocarcinoma, Serous; Etoposide; Female; Floxuridine; Follow-Up Studies; Heterozygote; Humans; Injections, Intraperitoneal; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Topotecan | 2014 |
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
[Second-line chemotherapy and its survival analysis of 181 patients with extensive-stage small cell lung cancer in a single institute].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma | 2013 |
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vincristine; Young Adult | 2014 |
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2014 |
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).
Topics: Adenine Nucleotides; Adolescent; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Probability; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2014 |
Orbital involvement by non-Hodgkin lymphoma NK T cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cytarabine; Ethmoid Sinus; Etoposide; Exophthalmos; Fatal Outcome; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinus; Methylprednisolone; Nasal Obstruction; Neoplasm Recurrence, Local; Orbit; Salvage Therapy; Tomography, X-Ray Computed | 2014 |
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Radiography; Risk Factors; Salvage Therapy; Time Factors; Treatment Outcome | 2014 |
Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisplatin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma; Survival Rate; Tumor Burden | 2014 |
Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2014 |
Successful treatment of metastatic βHCG-secreting germ cell tumor occurring 3 years after total resection of a pineal mature teratoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Pinealoma; Radiotherapy, Adjuvant; Teratoma; Treatment Outcome | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposide; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Neoplasm Recurrence, Local; Treatment Outcome | 2014 |
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Prognosis; Prospective Studies; Radionuclide Imaging; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Testicular Neoplasms | 2014 |
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Salvage Therapy; Sarcoma, Ewing; Survival Rate; Young Adult | 2015 |
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Vincristine; Young Adult | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Adjustment; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Transplantation Conditioning; Vincristine; Wilms Tumor | 2014 |
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Carmustine; Child; Cyclophosphamide; Etoposide; Female; Gamma Rays; Graft vs Host Disease; Hodgkin Disease; Humans; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2015 |
Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Capecitabine; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy | 2015 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organ Sparing Treatments; Ovarian Neoplasms; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients.
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents; Blood Circulation; Carcinoma; Cyclophosphamide; Etoposide; Female; Humans; Immunophenotyping; Middle Aged; Monitoring, Immunologic; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Prognosis; Prospective Studies; Sensitivity and Specificity; T-Lymphocytes, Regulatory; Treatment Outcome | 2015 |
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine | 2015 |
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2015 |
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Piperidines; Remission Induction; Rituximab | 2015 |
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum Compounds; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Topotecan; Treatment Outcome | 2015 |
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Polyethylene Glycols; Retrospective Studies; Treatment Outcome | 2015 |
Ovarian Cancer in Children and Adolescents: Treatment and Reproductive Outcomes.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Fertility; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Reproduction; Retrospective Studies; Survival Rate; Young Adult | 2015 |
Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
Topics: Cell Line, Tumor; Cisplatin; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Nuclear Proteins; Osteosarcoma | 2015 |
Sepsis caused by Listeria monocytogenes during chemotherapy for small cell carcinoma of the thymus.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cefepime; Cephalosporins; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Listeria monocytogenes; Listeriosis; Meropenem; Neoplasm Recurrence, Local; Sepsis; Thienamycins; Thymus Gland; Thymus Neoplasms; Treatment Outcome | 2015 |
Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Carbon Radioisotopes; Child; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Disease-Free Survival; Etoposide; False Positive Reactions; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lateral Ventricles; Male; Melphalan; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Tissue Distribution; Young Adult | 2015 |
A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis; Thalidomide; Treatment Outcome; Vincristine | 2015 |
Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulosa Cell Tumor; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taiwan; Young Adult | 2015 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Young Adult | 2015 |
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2015 |
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2015 |
Cutaneous metastasis as an initial presentation of a non-functioning pancreatic neuroendocrine tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Gastrectomy; Humans; Lymphatic Metastasis; Male; Metastasectomy; Middle Aged; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Reoperation; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chorionic Gonadotropin; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2015 |
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Induction Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2016 |
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Approval; Etoposide; Europe; Humans; International Cooperation; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Medical Oncology; Neoplasm Recurrence, Local; Oligopeptides; Prednisolone; Prognosis; Recurrence; Remission Induction; Risk; Treatment Outcome; United States; United States Food and Drug Administration; Vincristine | 2015 |
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Prognosis; Rituximab; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine | 2016 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult | 2016 |
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2016 |
Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Fluorescein Angiography; Humans; Infusions, Intra-Arterial; Intravitreal Injections; Magnetic Resonance Imaging; Male; Melphalan; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Seeding; Optic Nerve Neoplasms; Retinal Neoplasms; Retinoblastoma; Treatment Failure | 2016 |
Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients.
Topics: Antigens, CD34; Antineoplastic Agents; Epirubicin; Etoposide; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cells; Prospective Studies; Salvage Therapy | 2016 |
MYC/BCL2 double-hit lymphoma/leukemia mimicking acute leukemia at initial presentation.
Topics: Abnormal Karyotype; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Flow Cytometry; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia; Leukocytosis; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisone; Proto-Oncogene Proteins c-bcl-2; Rituximab; Vincristine | 2016 |
Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2016 |
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Young Adult | 2017 |
Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Spinal Cord Neoplasms; Teratoma; Treatment Outcome; Young Adult | 2017 |
Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Language Development Disorders; Lung Neoplasms; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nephrectomy; Pneumonectomy; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine | 2017 |
FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
Topics: Adenosine Triphosphatases; Adult; Aged; Apoptosis; ATPases Associated with Diverse Cellular Activities; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Homologous Recombination; Humans; Male; Microtubule-Associated Proteins; Middle Aged; Neoplasm Recurrence, Local; Nuclear Proteins; Signal Transduction; Small Cell Lung Carcinoma | 2017 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cisplatin; Compassionate Use Trials; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Nivolumab; Platinum Compounds; Programmed Cell Death 1 Receptor; Retrospective Studies; Seminoma; Stem Cell Transplantation; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome | 2017 |
Recurrent melanotic neuroectodermal tumor of infancy: a proposal for treatment protocol with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 7; Comparative Genomic Hybridization; Etoposide; Humans; Ifosfamide; Infant; Loss of Heterozygosity; Male; Mandibular Neoplasms; Neoplasm Recurrence, Local; Neuroectodermal Tumor, Melanotic; Vincristine | 2008 |
Clinical manifestations and treatment of retinoblastoma in Korea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye; Eye Enucleation; Female; Humans; Infant; Korea; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2008 |
The success of primary chemotherapy for group D heritable retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Germ-Line Mutation; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Treatment Outcome; Vincristine | 2009 |
Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Fatal Outcome; Female; Gestational Age; Humans; Hypothalamic Diseases; Infant; Infusions, Parenteral; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Tomography, X-Ray Computed; Topotecan; Vincristine | 2008 |
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Osteosarcoma; Pneumonectomy; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis | 2008 |
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2008 |
[Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, High-Energy; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2008 |
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2008 |
Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Sarcoma, Ewing; Treatment Outcome; Young Adult | 2009 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
[Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies | 2008 |
Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2009 |
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 2009 |
Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Etoposide; Female; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Treatment Outcome | 2009 |
Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Survival Analysis; Treatment Failure | 2009 |
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Management of pilomyxoid astrocytomas: our experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prognosis | 2009 |
Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2009 |
Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Seminoma; Testicular Neoplasms | 2009 |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy | 2009 |
[Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Survival Rate; Topotecan | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Pregnancy; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Survival Rate; Treatment Outcome; Trophoblastic Tumor, Placental Site; United Kingdom; Uterine Neoplasms; Vincristine | 2009 |
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Pulmonary Diffusing Capacity; Radiotherapy Dosage; Retrospective Studies | 2009 |
Oral etoposide for refractory or recurrent epithelial ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Analysis; Treatment Outcome | 2009 |
[Experience of the treatment for clinical Stage-1 seminoma over a period of 10 years].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Retrospective Studies; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2010 |
Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Young Adult | 2010 |
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiotherapy; Sarcoma; Treatment Outcome; Vincristine | 2010 |
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Young Adult | 2010 |
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2010 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune | 2010 |
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Salvage Therapy; Wilms Tumor | 2010 |
Malignant teratoma of the thyroid in a pregnant woman.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Teratoma; Thyroid Neoplasms | 2010 |
Fertility in women after surgical treatment of nonepithelial ovarian tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fertility; Humans; Hysterectomy; Infertility, Female; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Retrospective Studies; Young Adult | 2010 |
Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2011 |
Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Chest wall Ewing sarcoma family of tumors: long-term outcomes.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Radiotherapy Dosage; Sarcoma, Ewing; Thoracic Wall; Time Factors; Vincristine; Young Adult | 2011 |
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy; Salvage Therapy; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Which therapy works better in choroid plexus carcinomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choroid Plexus Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Radiotherapy; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion.
Topics: Adolescent; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Child; Child, Preschool; Chromosome Aberrations; Comet Assay; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Polymorphism, Single Nucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Salvaging AML with CLAG: novel option, or more of the same?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome | 2011 |
Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2011 |
[Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2010 |
Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Female; Fibrosis; Humans; Infant; Injections, Intraocular; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Seeding; Orbit; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2010 |
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan | 2010 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
Multifaceted chemotherapy for trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Salvage Therapy; Seminoma; Survival Rate; Testicular Neoplasms | 2013 |
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Topotecan; Treatment Outcome | 2011 |
Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large-Cell, Anaplastic; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Stem Cell Transplantation; Transplantation, Homologous; Young Adult | 2012 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult | 2011 |
Fertility sparing surgery for ovarian tumors in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Ovarian Cysts; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prospective Studies; Young Adult | 2012 |
[Bilateral conjunctival oedema as a symptom of adrenal adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Conjunctival Diseases; Cushing Syndrome; Cyclophosphamide; Diabetes Mellitus, Type 2; Doxorubicin; Edema; Etoposide; Fatal Outcome; Female; Humans; Hydrocortisone; Ketoconazole; Lung Neoplasms; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Respiratory Insufficiency; Vincristine | 2011 |
Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Time Factors; Young Adult | 2013 |
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD56 Antigen; Chromosomes, Human, Pair 11; Cyclophosphamide; Dendritic Cells; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Male; Neoplasm Recurrence, Local; Prednisolone; Skin; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
Retained role of surgery for olfactory neuroblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Audit; Clinical Protocols; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Male; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Young Adult | 2011 |
Avastin: more questions than answers. . .
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Dacarbazine; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Supratentorial Neoplasms; Temozolomide | 2012 |
Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cancer Vaccines; Chromatography, Liquid; Dendritic Cells; Doxorubicin; Etoposide; Female; Hep G2 Cells; Humans; Neoplasm Recurrence, Local; Proteomics; Receptors, Cell Surface; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured | 2012 |
Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Busulfan; Carboplatin; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Melphalan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Vidarabine; Vincristine | 2011 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome | 2012 |
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Young Adult | 2012 |
Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Carboplatin; Child; Chromosome Duplication; Chromosomes, Human, Pair 1; Etoposide; Humans; Ifosfamide; Male; Mesna; Neoplasm Recurrence, Local; Rituximab | 2012 |
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemianopsia; Hodgkin Disease; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 2012 |
Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Space; Retrospective Studies; Teratoma; Testicular Neoplasms; Young Adult | 2012 |
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Electrophoresis, Gel, Two-Dimensional; Etoposide; Follow-Up Studies; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Mitochondrial Trifunctional Protein; Mitochondrial Trifunctional Protein, alpha Subunit; Multienzyme Complexes; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Small Cell Lung Carcinoma; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2011 |
Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Electrophysiology; Electroretinography; Etoposide; Female; Humans; Infusions, Intra-Arterial; Melphalan; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2012 |
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult | 2012 |
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cytarabine; Daunorubicin; Etoposide; Gene Expression; Gene Expression Regulation, Neoplastic; Hepatomegaly; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Muscle Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Splenomegaly; Treatment Outcome; Up-Regulation; Young Adult | 2012 |
The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2012 |
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2012 |
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Time Factors | 2012 |
Benefit of a second opinion for lung cancer: no recurrent disease, but infection.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pemetrexed; Postoperative Care; Prognosis; Referral and Consultation | 2012 |
Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed | 2012 |
Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Follow-Up Studies; Half-Life; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Testicular Neoplasms; Young Adult | 2012 |
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Sarcoma, Synovial; Treatment Outcome | 2012 |
Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Remission Induction; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials, Phase II as Topic; Cohort Studies; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult | 2012 |
Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiotherapy, Adjuvant; Risk Factors; Seminoma; Testicular Neoplasms | 2012 |
Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Topics: Administration, Intravenous; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Injections, Intra-Arterial; Injections, Intraocular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2013 |
Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Remission Induction; Reoperation; Retrospective Studies; Risk Factors; Thoracotomy; Tracheostomy; Treatment Failure; Treatment Outcome | 2013 |
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Etoposide; Female; Humans; Male; Medical Oncology; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2012 |
Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Time Factors; Transplantation, Autologous; Treatment Outcome | 2013 |
[Treatment of recurrent ovarian cancer].
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyethylene Glycols; Reoperation; Topotecan | 2012 |
Local recurrence of gastric cancer after total gastrectomy: an unusual presentation.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Fluorouracil; Gastrectomy; Humans; Levoleucovorin; Male; Neoplasm Recurrence, Local; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel | 2012 |
Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Tumor Burden | 2013 |
Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Female; Humans; Induction Chemotherapy; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma; Time Factors; Topotecan; Treatment Outcome | 2015 |
Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Division; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vincristine | 2002 |
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies | 2002 |
A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Female; Humans; Hypopituitarism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Treatment Outcome; Vincristine | 2002 |
[Recurrence of intracranial germinoma initially treated with chemotherapy only].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Etoposide; Fatal Outcome; Follow-Up Studies; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Treatment Outcome | 2002 |
Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Colonic Neoplasms; Etoposide; Fatal Outcome; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Serpins; Tomography, X-Ray Computed | 2001 |
Thermochemotherapy in hereditary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2003 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Topics: Acute Disease; Adolescent; Amino Acid Sequence; Child; Child, Preschool; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; DNA-Binding Proteins; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myeloid; Male; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nuclear Proteins; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Transcription Factors; Tumor Cells, Cultured | 2003 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Peritoneal Neoplasms; Teratoma; Testicular Neoplasms | 2003 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2003 |
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation | 2003 |
Options for first- and second-line therapy in small cell lung cancer--a workshop discussion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local | 2003 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Survival Rate; Vincristine | 2003 |
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
[Alternating electric heart axis in a patient with small cell lung cancer].
Topics: Abdominal Pain; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Echocardiography; Electrocardiography; Etoposide; Heart Conduction System; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pericardial Effusion; Pericardiocentesis | 2004 |
Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Sarcoma, Ewing | 2003 |
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Irinotecan; L-Lactate Dehydrogenase; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
[Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy].
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Polymers | 2004 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Medical Records; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2004 |
Commenting on "Vulvar langerhans cell histocytosis: a case report and review of the literature" by Santillan et al. 91:241-246.
Topics: Child, Preschool; Combined Modality Therapy; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Neoplasm Recurrence, Local; Vinblastine; Vulvar Diseases | 2004 |
Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy.
Topics: Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Iran; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Treatment Failure | 2004 |
Primary omental synovial sarcoma: a case with cytogenetic confirmation.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Maternal Age; Mesna; Neoplasm Recurrence, Local; Omentum; Peritoneal Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, High-Risk; Sarcoma, Synovial | 2004 |
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome; Wilms Tumor | 2004 |
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome; Vincristine | 2004 |
What is the best treatment for retinoblastoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Humans; Hyperthermia, Induced; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2004 |
Recurrence of a non-seminomatous germ cell tumor in the seminal vesicle 20 years after initial diagnosis and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Seminal Vesicles; Testicular Neoplasms; Time Factors; Treatment Outcome | 2004 |
Placental site trophoblastic tumor: an overview.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placenta Diseases; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Salvage Therapy; Uterine Neoplasms | 2004 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Failure; Vincristine | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
Late relapse of stage I testicular seminoma metastatic to just a para-ureteropelvic region.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Humans; Hydronephrosis; Kidney Pelvis; Male; Neoplasm Recurrence, Local; Seminoma; Testicular Neoplasms; Ureteral Neoplasms | 2004 |
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation; Cervical Atlas; Chemotherapy, Adjuvant; Chondrosarcoma; Chordoma; Combined Modality Therapy; Cranial Fossa, Posterior; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Ifosfamide; Interdisciplinary Communication; Internal Fixators; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Palliative Care; Patient Care Team; Proton Therapy; Remission Induction; Skull Base Neoplasms; Spinal Fusion; Spinal Neoplasms; Surgical Flaps | 2004 |
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Quinazolines; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome | 2005 |
VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Salvage Therapy; Sarcoma, Ewing; Survival Analysis | 2004 |
Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Humans; Laser Therapy; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome | 2005 |
Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Vincristine | 2004 |
Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Cisplatin; Craniopharyngioma; Etoposide; Fatal Outcome; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms | 2004 |
[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thrombocytopenia; Transplantation, Autologous | 2005 |
Medulloblastoma in two successive pregnancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Medulloblastoma; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vincristine | 2005 |
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Pelvic recurrence in stage I seminoma: a new phenomenon that questions modern protocols for radiotherapy and follow-up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Pelvic Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2005 |
Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2005 |
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2005 |
Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous | 2005 |
Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Heart Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Remission Induction; Sarcoma, Myeloid; Transplantation, Homologous | 2005 |
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome | 2006 |
Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Choriocarcinoma; Etoposide; Feasibility Studies; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Orchiectomy; Prognosis; Risk Management; Seminoma; Survival Rate; Teratoma; Testicular Neoplasms | 2005 |
Treatment with oral etoposide for childhood recurrent ependymomas.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2005 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Medulloblastoma; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiosurgery; Radiotherapy Dosage; Retrospective Studies | 2006 |
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Camptothecin; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Vascular Endothelial Growth Factor A | 2006 |
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurosurgical Procedures; Radiotherapy; Seminoma; Vinblastine | 2006 |
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine | 2006 |
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Busulfan; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome | 2006 |
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2006 |
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Child; Etoposide; Ganglioneuroblastoma; Ganglioneuroma; GPI-Linked Proteins; Humans; Inhibitor of Apoptosis Proteins; Membrane Glycoproteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasm Recurrence, Local; Neuroblastoma; Predictive Value of Tests; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2006 |
Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; China; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2006 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Vault Ribonucleoprotein Particles | 2006 |
Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Etoposide; Eye Diseases; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2006 |
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan | 2008 |
Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Klinefelter Syndrome; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Puberty, Precocious; Reoperation; Teratoma | 2006 |
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intraoperative Complications; Laser Therapy; Male; Neoplasm Recurrence, Local; Postoperative Complications; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2007 |
[Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Survival Rate; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine | 2006 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2006 |
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2006 |
ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma.
Topics: Adult; Alpha-Globulins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Platelet Factor 4; Protein Array Analysis; Protein Precursors; Salvage Therapy | 2007 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
Acute respiratory distress in a bleomycin primed patient: a new use for nitric oxide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Nitric Oxide; Respiratory Distress Syndrome; Retroperitoneal Neoplasms; Testicular Neoplasms | 2007 |
Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2007 |
Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic | 2007 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Prognosis; Remission Induction | 2007 |
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Hemangiosarcoma; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2008 |
Malignant teratoid/rhabdoid tumour: long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rhabdoid Tumor; Survivors; Teratoma; Treatment Outcome; Vincristine | 2007 |
Multimodal treatment of thymic carcinoma: Report of nine cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Thymoma | 2008 |
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Captopril; Cisplatin; Diarrhea; Doxorubicin; Etoposide; Female; Heart Failure; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Hypokalemia; Ketoconazole; Mineralocorticoid Receptor Antagonists; Mitotane; Neoplasm Recurrence, Local; Potassium; Rhabdomyolysis; Spironolactone; Tachycardia | 2007 |
Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine | 2007 |
Long-term follow-up of 5 patients with intracranial germinoma initially treated by chemotherapy alone.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Basal Ganglia Diseases; Brain Neoplasms; Child; Cisplatin; Endocrine System Diseases; Etoposide; Female; Germinoma; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Pineal Gland; Pituitary Gland, Posterior; Pituitary Neoplasms; Recovery of Function; Remission Induction; Retreatment | 2007 |
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents; Ataxia; Child; Child, Preschool; Cohort Studies; Cyclosporins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Feasibility Studies; Female; Gastrointestinal Diseases; Humans; Infant; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local | 2007 |
[Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Testicular Neoplasms | 2007 |
Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Rhabdoid Tumor; Salvage Therapy; Survivors; Thoracic Neoplasms; Vincristine | 2007 |
[Long-term follow-up of patients with suprasellar germinomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diabetes Insipidus; Disease Progression; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Hypopituitarism; Ifosfamide; Male; Neoplasm Recurrence, Local; Paraneoplastic Endocrine Syndromes; Pituitary Irradiation; Pituitary Neoplasms; Survival Rate | 2007 |
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Etoposide; Humans; Interferon-alpha; Interferon-gamma; Male; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nephrectomy; Thiotepa | 2007 |
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine | 2008 |
[Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vomiting; Young Adult | 2007 |
Prognostic factors for local and distant control in Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Incidence; Infant; Male; Medical Records; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Treatment Failure | 2008 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Mitoguazone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Vincristine | 2008 |
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 2008 |
Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 2007 |
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2008 |
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2008 |
Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Young Adult | 2008 |
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Assessment; Salvage Therapy; Survival Analysis | 2008 |
Primary small cell carcinoma of the breast.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Irinotecan; Liver Neoplasms; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Thoracic Wall | 2009 |
VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Topics: Adolescent; Adult; Cisplatin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms | 1982 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Vincristine | 1982 |
Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1982 |
Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed | 1984 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1982 |
Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Uterine Neoplasms | 1982 |
Metastatic adamantinoma of bone to lung. A case report of the natural history and the use of chemotherapy and radiation therapy.
Topics: Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Postoperative Care; Radiotherapy Dosage; Tibia | 1994 |
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Genital Neoplasms, Male; Germinoma; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine; Vincristine | 1994 |
Remission of recurrent primary intracranial malignant lymphoma after high-dose intra-arterial corticosteroid administration and intra-arterial chemotherapy--case report.
Topics: Adrenal Cortex Hormones; Adult; Brain; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous | 1994 |
[Successful treatment with combined chemotherapy (carboplatin, etoposide, adriamycin, bleomycin) and radiotherapy for recurrent intracranial malignant germ cell tumor: case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Germinoma; Humans; Neoplasm Recurrence, Local | 1995 |
Prolonged oral etoposide for refractory advanced uterine leiomyosarcoma.
Topics: Administration, Oral; Aged; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Neoplasm Recurrence, Local; Uterine Neoplasms | 1995 |
Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16).
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Teratoma | 1993 |
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Risk Factors; Testicular Neoplasms | 1993 |
[Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma. Study of 51 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 1994 |
[Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
Topics: Adenocarcinoma; Administration, Oral; Aged; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local | 1995 |
Refining therapeutic strategies for patients with resistant Wilm's tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Medical Records; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Wilms Tumor | 1994 |
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia | 1994 |
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate | 1994 |
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate | 1993 |
Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Pilot Projects; Remission Induction; Retinoblastoma | 1994 |
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1994 |
[Soft tissue tumors: indications and results of hyperthermia].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Soft Tissue Neoplasms; Survival Rate | 1993 |
[Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1993 |
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome | 1993 |
Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction | 1993 |
[Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Vomiting | 1993 |
Recurrent brainstem gliomas treated with oral VP-16.
Topics: Administration, Oral; Adolescent; Adult; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1993 |
[The value of etoposide (VP-16) in the therapy of refractory ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cause of Death; Cystadenocarcinoma; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate | 1993 |
Response of recurrent medulloblastoma to low-dose oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local | 1996 |
Late relapse after autologous BMT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Time Factors | 1996 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms | 1996 |
Chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Germinoma; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Salvage Therapy; Survival Rate; Vincristine | 1996 |
[Chemosensitivity of cultured meningiomas].
Topics: Antineoplastic Agents; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Humans; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Nimustine; Tumor Cells, Cultured | 1995 |
Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Eosinophilia; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Remission Induction; Translocation, Genetic | 1996 |
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Pilot Projects; Survival Rate; Thiotepa; Transplantation, Autologous | 1996 |
Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glaucoma, Neovascular; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinoblastoma; Survival Rate; Vincristine; Visual Acuity | 1996 |
[A pilot study of low dose etoposide therapy for recurrenced prostate cancer in complicated over 75 years old stage D2 cases].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prostatic Neoplasms | 1996 |
Long-lasting complete remission after prolonged administration of etoposide in a child with a second recurrence of alveolar rhabdomyosarcoma.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Remission Induction; Rhabdomyosarcoma, Alveolar; Thigh; Time Factors | 1997 |
Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Fundus Oculi; Humans; Hypothermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Retinoblastoma | 1996 |
Craniospinal dissemination of central neurocytoma. Report of two cases.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebral Ventricle Neoplasms; Cisplatin; Cyclophosphamide; Dura Mater; Etoposide; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplastic Cells, Circulating; Neurocytoma; Septum Pellucidum; Spinal Cord Neoplasms | 1997 |
Residual mass following chemotherapy of seminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Fibrosis; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Vinblastine | 1997 |
Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Forearm; Hemangiopericytoma; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoplasm Recurrence, Local; Salvage Therapy; Thoracic Neoplasms | 1997 |
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palliative Care; Prognosis; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 1997 |
Multidrug-resistant gene expression in small-cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Immunoblotting; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Survival Analysis; Survival Rate; Transcription, Genetic; Treatment Failure; Tumor Cells, Cultured; Vincristine | 1997 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies | 1998 |
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1998 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous | 1998 |
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cisplatin; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome | 1998 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia | 1998 |
Ovarian germ cell tumors.
Topics: Adolescent; Adult; Age Distribution; Aged; Anthramycin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Gynecologic Surgical Procedures; Humans; Incidence; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Prognosis; Retrospective Studies; Spain; Survival Rate | 1998 |
[CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Remission Induction; Uterine Cervical Neoplasms | 1998 |
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Wilms Tumor | 1998 |
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 1998 |
Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Etoposide; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1998 |
Long term results of surgery and chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine | 1998 |
[A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neutropenia; Seminoma; Testicular Neoplasms | 1998 |
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Stem Cells | 1998 |
Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphocytic leukemia.
Topics: Age Factors; Antigens, CD34; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Fetal Blood; Follow-Up Studies; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Infant; Leukocyte Count; Male; Neoplasm Recurrence, Local; Neprilysin; Neutrophils; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 1999 |
Rapid progression of squamous cell carcinoma of the cervix after hyperbaric oxygenation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Hyperbaric Oxygenation; Lymph Node Excision; Lymphatic Diseases; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
Chemotherapy in patients with recurrent and progressive central neurocytoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurocytoma; Treatment Outcome | 2000 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Thrombocytopenia; Transplantation, Autologous | 2000 |
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic plac
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placenta; Pregnancy; Remission Induction; Risk Factors; Survival Rate; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
[Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies | 1998 |
Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Nucleic Acid Synthesis Inhibitors; Skin Neoplasms | 2000 |
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Databases as Topic; England; Etoposide; Female; Follow-Up Studies; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Registries; Salvage Therapy; Time Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
No responses to oral etoposide in 15 patients with recurrent brain tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2000 |
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infections; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Sweden; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Methotrexate infusion in low-risk gestational trophoblastic disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Hydatidiform Mole; Infusions, Intravenous; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prospective Studies; Remission Induction; Risk Factors | 2000 |
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine | 2001 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting | 2001 |
Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Prospective Studies; Topotecan | 2001 |
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Brain Diseases; Brain Neoplasms; Cachexia; Cerebral Hemorrhage; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Survival Rate; Thiotepa; Treatment Failure; Vincristine | 2000 |
Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Stomach Neoplasms | 2001 |
Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Ependymoma; Estrogen Receptor Modulators; Etoposide; Female; Humans; Laminectomy; Low Back Pain; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Spinal Cord Neoplasms; Tamoxifen; Treatment Outcome | 2001 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome | 2001 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine | 2001 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
Primary gastric choriocarcinoma: a case report and review of the literature.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Salvage Therapy; Stomach Neoplasms; Tomography, X-Ray Computed | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine | 2001 |
Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies; Regression Analysis; Retreatment; Salvage Therapy | 2002 |
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2002 |
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Treatment Outcome | 2001 |
Weekly platinum chemotherapy for recurrent ovarian cancer.
Topics: Administration, Oral; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2002 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2001 |
Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Retrospective Studies; Survival Rate; Treatment Outcome | 2002 |
Influence of phenytoin on the disposition of irinotecan: a case report.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Disease Progression; Drug Interactions; Enzyme Induction; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Melphalan; Mixed Function Oxygenases; Neoplasm Recurrence, Local; Ondansetron; Phenobarbital; Phenytoin; Pineal Gland; Pinealoma; Prodrugs; Salvage Therapy; Seizures | 2002 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infections; Ki-67 Antigen; Lymphocytes, Null; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Melanoma; Neoplasm Recurrence, Local; Neutrophils; Prednisone; Radiotherapy, Adjuvant; T-Lymphocytes; Vincristine | 2002 |
[Clinical and therapeutic study (phase II) using VP-16/213 and methyl-CCNU in patients with inoperable, recurring or metastasizing carcinomas of the gastriointestinal tract].
Topics: Adult; Aged; Colonic Neoplasms; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Stomach Neoplasms; Terminal Care; Time Factors | 1978 |
Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Pilot Projects; Teratoma; Testicular Neoplasms | 1992 |
Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Vincristine | 1992 |
[BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Dysgerminoma; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1992 |
[Treatment of recurrent ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Parenteral; Lymph Node Excision; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Paclitaxel | 1992 |
Cardiac tamponade resulting from recurrent small-cell carcinoma of the uterine cervix temporarily responding to CE/CAV chemotherapy: report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cardiac Tamponade; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine | 1992 |
Recurrent intracranial germinoma refractory to conventional irradiation: effective chemotherapy consisting of cisplatin and etoposide--case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Diabetes Insipidus; Etoposide; Humans; Lumbar Vertebrae; Male; Neoplasm Recurrence, Local; Pinealoma; Postoperative Complications; Radiation Tolerance; Remission Induction; Sacrum; Spinal Neoplasms | 1992 |
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Survival Rate | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Transplantation, Autologous | 1992 |
Choroid plexus carcinoma--responses to chemotherapy alone in newly diagnosed young children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Etoposide; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Radiography | 1992 |
High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease.
Topics: Adult; Bone Marrow Transplantation; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy | 1992 |
[Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1992 |
Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neurologic Examination; Tomography, X-Ray Computed | 1992 |
Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Survival Rate; Vincristine | 1991 |
A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nimustine; Pneumonectomy; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vincristine | 1991 |
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Vincristine | 1991 |
Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Risk Factors; Testicular Neoplasms | 1990 |
Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Colony-Stimulating Factors; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Remission Induction; Survival Rate | 1990 |
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Vincristine | 1990 |
Failure of salvage treatment in metastatic testicular teratoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Survival Rate; Teratoma; Testicular Neoplasms; Vinblastine | 1991 |
[A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
Topics: Administration, Oral; Cystadenocarcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1992 |
[A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local | 1992 |
Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1991 |
[Preliminary report on the effect of etoposide or etoposide and CDDP on recurrent prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms | 1991 |
Chemoimmunotherapy in conjunction with surgery: strategies for management of murine neuroblastoma.
Topics: Animals; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Liver Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Recurrence, Local; Neuroblastoma; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nephrectomy; Remission Induction; Tomography, X-Ray Computed; Wilms Tumor | 1991 |
VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Reoperation; Risk Factors; Whole-Body Irradiation | 1991 |
[Two cases of Ewing's sarcoma originating from the adult rib].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Ribs; Sarcoma, Ewing | 1991 |
Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leg; Male; Neoplasm Recurrence, Local; Osteosarcoma; Probability; Proportional Hazards Models; Remission Induction | 1991 |
Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Whole-Body Irradiation | 1991 |
21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Dysgerminoma; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Prognosis; Testicular Neoplasms | 1990 |
Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carmustine; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors | 1990 |
Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1991 |
Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone | 1991 |
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction | 1991 |
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms | 1990 |
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Transplantation, Autologous | 1990 |
[A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Stomach Neoplasms | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
Combined modality therapy for locally advanced non-small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Radiation Injuries; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed | 1990 |
[Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Myocardial Infarction; Neoplasm Recurrence, Local | 1990 |
[Endodermal sinus tumor. Histological changes induced by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant, Newborn; Liver Neoplasms; Male; Mesonephroma; Neoplasm Recurrence, Local; Sacrococcygeal Region; Teratoma; Time Factors | 1990 |
Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy.
Topics: Child; Child, Preschool; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Infant, Newborn; Male; Neoplasm Recurrence, Local; Remission Induction | 1990 |
Treatment of relapsed or refractory acute leukemia: comparison of two different regimens.
Topics: Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Leukemia; Mitoxantrone; Neoplasm Recurrence, Local | 1990 |
Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction | 1990 |
Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Dysgerminoma; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Time Factors; Vinblastine; Vomiting | 1985 |
Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; Male; Mesonephroma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms | 1985 |
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1985 |
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Time Factors | 1985 |
Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Risk; Teratoma; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 1986 |
Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1986 |
Cisplatin-based treatment of adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms | 1987 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Treatment of disseminated germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine | 1989 |
[Treatment of stage I-IIB nonseminomatous testicular tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Retrospective Studies; Testicular Neoplasms; Vinblastine | 1989 |
Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Dysgerminoma; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Postoperative Care; Radiotherapy; Testicular Neoplasms | 1989 |
Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 1989 |
Ifosfamide in testicular cancer: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1989 |
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pneumonia; Radiation Injuries; Remission Induction; Thrombocytopenia; Vincristine | 1989 |
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Parity; Pregnancy; Prognosis; Remission Induction; Trophoblastic Neoplasms; Uterine Neoplasms | 1989 |
[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1989 |
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Time Factors | 1989 |
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Mitoxantrone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms | 1989 |
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Risk Factors | 1989 |
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms | 1989 |
Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in a xenograft model.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Humans; Kidney Neoplasms; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Nephrectomy; Recombinant Proteins; Remission Induction; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1989 |
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 1989 |
[A case of recurrent uterine cervical cancer successfully treated with etoposide].
Topics: Administration, Oral; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prognosis; Uterine Cervical Neoplasms | 1989 |
[Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms | 1989 |
Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Vincristine | 1987 |
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds | 1987 |
Etoposide (VP-16) and cytosine arabinoside in the treatment of relapsed small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cytarabine; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 1988 |
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1989 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Fever; Follow-Up Studies; Humans; Male; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Prognosis; Teratoma | 1985 |
Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Vincristine | 1985 |
Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hormones, Ectopic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Vincristine | 1985 |
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 1985 |
Primary oral etoposide therapy in gestational trophoblastic disease. An update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Etoposide; Female; Humans; Hydatidiform Mole; Hysterectomy; Lung Neoplasms; Neoplasm Recurrence, Local; Podophyllotoxin; Pregnancy; Risk; Trophoblastic Neoplasms; Uterine Neoplasms; Vaginal Neoplasms | 1986 |
Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tumor Stem Cell Assay | 1986 |
Chemotherapy for gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Luteinizing Hormone; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
Topics: Aged; Aged, 80 and over; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Uterine Neoplasms | 1987 |
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Combined Modality Therapy; Cystitis; Drug Evaluation; Etoposide; Humans; Ifosfamide; Mesna; Neoplasm Recurrence, Local; Sarcoma | 1987 |
Improved prognosis for children with stage IV neuroblastoma: high-dose melphalan and autologous unpurged marrow transplantation after aggressive surgery and short chemotherapy with cisplatinum and etoposide.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Transplantation, Autologous; Tumor Lysis Syndrome | 1988 |
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Neoplasm Recurrence, Local; Remission Induction | 1988 |
Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine.
Topics: Adult; Amsacrine; Blood Transfusion; Drug Therapy, Combination; Etoposide; Factor IX; Factor X; Factor X Deficiency; Humans; Hypoprothrombinemias; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prothrombin; Prothrombin Time | 1988 |
A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local | 1988 |
High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Whole-Body Irradiation | 1987 |
Respiratory tract fistulae in recurrent aerodigestive cancers after chemotherapy.
Topics: Bronchial Fistula; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography | 1988 |
Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors. A phase II study from the Pediatric Oncology Group.
Topics: Adolescent; Adult; Blood Cell Count; Child; Child, Preschool; Drug Evaluation; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasms | 1988 |
Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms | 1987 |
[Etoposide in the treatment of recurrent malignant lymphoma].
Topics: Adolescent; Adult; Aged; Etoposide; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1986 |
EVA treatment for recurrent or unresponsive Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Vincristine | 1986 |
"Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma".
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1986 |
Treatment for recurrent ovarian cancer. A report of 2 cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1987 |
Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Sarcoma | 1987 |
High-dose etoposide in the treatment of relapsed primary brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1985 |